{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 805968, "items": [{"indexed": {"date-parts": [[2019, 11, 18]], "date-time": "2019-11-18T22:49:42Z", "timestamp": 1574117382583}, "reference-count": 35, "publisher": "Proceedings of the National Academy of Sciences", "issue": "18", "content-domain": {"domain": ["pnas.org"], "crossmark-restriction": true}, "short-container-title": ["Proceedings of the National Academy of Sciences"], "published-print": {"date-parts": [[1998, 9, 1]]}, "DOI": "10.1073/pnas.95.18.10860", "type": "journal-article", "created": {"date-parts": [[2002, 7, 26]], "date-time": "2002-07-26T14:40:11Z", "timestamp": 1027694411000}, "page": "10860-10865", "update-policy": "http://dx.doi.org/10.1073/pnas.cm10313", "source": "Crossref", "is-referenced-by-count": 302, "title": ["ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex"], "prefix": "10.1073", "volume": "95", "author": [{"given": "J.", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "T.", "family": "Hoshino", "sequence": "additional", "affiliation": []}, {"given": "R. L.", "family": "Redner", "sequence": "additional", "affiliation": []}, {"given": "S.", "family": "Kajigaya", "sequence": "additional", "affiliation": []}, {"given": "J. M.", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "341", "reference": [{"issue": "5340", "key": "1_5784041", "doi-asserted-by": "publisher", "first-page": "1059", "DOI": "10.1126/science.278.5340.1059", "volume": "278", "author": "Look", "year": "1997", "journal-title": "Science", "ISSN": "http://id.crossref.org/issn/0036-8075", "issn-type": "print"}, {"issue": "23", "key": "2_9650700", "doi-asserted-by": "publisher", "first-page": "10431", "DOI": "10.1073/pnas.88.23.10431", "volume": "88", "author": "Miyoshi", "year": "1991", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "7", "key": "3_21320550", "first-page": "1825", "volume": "80", "author": "Erickson", "year": "1992", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "7", "key": "4_23309312", "first-page": "2715", "volume": "12", "author": "Miyoshi", "year": "1993", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "10", "key": "5_14553360", "doi-asserted-by": "publisher", "first-page": "338", "DOI": "10.1016/0168-9525(93)90026-E", "volume": "9", "author": "Kagoshima", "year": "1993", "journal-title": "Trends in genetics : TIG", "ISSN": "http://id.crossref.org/issn/0168-9525", "issn-type": "print"}, {"issue": "4", "key": "6_16521233", "doi-asserted-by": "publisher", "first-page": "697", "DOI": "10.1016/S0092-8674(00)81389-6", "volume": "87", "author": "Wang", "year": "1996", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "2", "key": "7_16163038", "doi-asserted-by": "publisher", "first-page": "321", "DOI": "10.1016/S0092-8674(00)80986-1", "volume": "84", "author": "Okuda", "year": "1996", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "4", "key": "8_15805670", "doi-asserted-by": "crossref", "first-page": "1974", "DOI": "10.1128/MCB.15.4.1974", "volume": "15", "author": "Meyers", "year": "1995", "journal-title": "Molecular and Cellular Biology", "ISSN": "http://id.crossref.org/issn/0270-7306", "issn-type": "print"}, {"issue": "12", "key": "9_16143344", "first-page": "2667", "volume": "11", "author": "Frank", "year": "1995", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "3", "key": "10_16706477", "doi-asserted-by": "publisher", "first-page": "303", "DOI": "10.1038/ng0397-303", "volume": "15", "author": "Yergeau", "year": "1997", "journal-title": "Nature genetics", "ISSN": "http://id.crossref.org/issn/1061-4036", "issn-type": "print"}, {"issue": "5", "key": "11_21324897", "first-page": "1813", "volume": "88", "author": "Erickson", "year": "1996", "journal-title": "Blood", "ISSN": "http://id.crossref.org/issn/0006-4971", "issn-type": "print"}, {"issue": "14", "key": "12_16852744", "first-page": "2951", "volume": "57", "author": "Wang", "year": "1997", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "7", "key": "13_14698456", "first-page": "1782", "volume": "54", "author": "Erickson", "year": "1994", "journal-title": "Cancer Research", "ISSN": "http://id.crossref.org/issn/0008-5472", "issn-type": "print"}, {"issue": "9", "key": "14_16080328", "first-page": "1761", "volume": "11", "author": "Lenny", "year": "1995", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "6628", "key": "15_16770743", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1038/387043a0", "volume": "387", "author": "Heinzel", "year": "1997", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6628", "key": "16_16770744", "doi-asserted-by": "publisher", "first-page": "49", "DOI": "10.1038/387049a0", "volume": "387", "author": "Alland", "year": "1997", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6548", "key": "17_16021147", "doi-asserted-by": "publisher", "first-page": "397", "DOI": "10.1038/377397a0", "volume": "377", "author": "H\u00a0\u00a0rlein", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6548", "key": "18_16021159", "doi-asserted-by": "publisher", "first-page": "451", "DOI": "10.1038/377451a0", "volume": "377", "author": "Kurokawa", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6548", "key": "19_16021160", "doi-asserted-by": "publisher", "first-page": "454", "DOI": "10.1038/377454a0", "volume": "377", "author": "Chen", "year": "1995", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "3", "key": "20_16780033", "doi-asserted-by": "publisher", "first-page": "373", "DOI": "10.1016/S0092-8674(00)80218-4", "volume": "89", "author": "Nagy", "year": "1997", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "1", "key": "21_4864181", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/0092-8674(88)90522-3", "volume": "52", "author": "Evans", "year": "1988", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "2", "key": "22_16130936", "first-page": "573", "volume": "140", "author": "Feinstein", "year": "1995", "journal-title": "Genetics", "ISSN": "http://id.crossref.org/issn/0016-6731", "issn-type": "print"}, {"issue": "8", "key": "23_23310964", "first-page": "1961", "volume": "15", "author": "Gross", "year": "1996", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "8", "key": "24_9515106", "doi-asserted-by": "crossref", "first-page": "4177", "DOI": "10.1128/MCB.11.8.4177", "volume": "11", "author": "Owens", "year": "1991", "journal-title": "Molecular and Cellular Biology", "ISSN": "http://id.crossref.org/issn/0270-7306", "issn-type": "print"}, {"issue": "2", "key": "25_16314957", "first-page": "303", "volume": "13", "author": "Meyers", "year": "1996", "journal-title": "Oncogene", "ISSN": "http://id.crossref.org/issn/0950-9232", "issn-type": "print"}, {"issue": "11", "key": "26_23395516", "doi-asserted-by": "publisher", "first-page": "2994", "DOI": "10.1093/emboj/17.11.2994", "volume": "17", "author": "Kitabayashi", "year": "1998", "journal-title": "The EMBO Journal", "ISSN": "http://id.crossref.org/issn/0261-4189", "issn-type": "print"}, {"issue": "6589", "key": "27_16302098", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1038/382319a0", "volume": "382", "author": "Yang", "year": "1996", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "5", "key": "28_16538367", "doi-asserted-by": "publisher", "first-page": "953", "DOI": "10.1016/S0092-8674(00)82001-2", "volume": "87", "author": "Ogryzko", "year": "1996", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "17", "key": "29_16880259", "doi-asserted-by": "publisher", "first-page": "9028", "DOI": "10.1073/pnas.94.17.9028", "volume": "94", "author": "Hong", "year": "1997", "journal-title": "PNAS", "ISSN": "http://id.crossref.org/issn/0027-8424", "issn-type": "print"}, {"issue": "1", "key": "30_16377238", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1038/ng0996-33", "volume": "14", "author": "Borrow", "year": "1996", "journal-title": "Nature genetics", "ISSN": "http://id.crossref.org/issn/1061-4036", "issn-type": "print"}, {"issue": "3", "key": "31_16780030", "doi-asserted-by": "publisher", "first-page": "349", "DOI": "10.1016/S0092-8674(00)80215-9", "volume": "89", "author": "Laherty", "year": "1997", "journal-title": "Cell", "ISSN": "http://id.crossref.org/issn/0092-8674", "issn-type": "print"}, {"issue": "6667", "key": "32_5887286", "doi-asserted-by": "publisher", "first-page": "597", "DOI": "10.1038/35404", "volume": "391", "author": "Brehm", "year": "1998", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6667", "key": "33_5887287", "doi-asserted-by": "publisher", "first-page": "601", "DOI": "10.1038/35410", "volume": "391", "author": "Magnaghi-Jaulin", "year": "1998", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6669", "key": "34_5904444", "doi-asserted-by": "publisher", "first-page": "811", "DOI": "10.1038/35895", "volume": "391", "author": "Lin", "year": "1998", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}, {"issue": "6669", "key": "35_5904445", "doi-asserted-by": "publisher", "first-page": "815", "DOI": "10.1038/35901", "volume": "391", "author": "Grignani", "year": "1998", "journal-title": "Nature; Physical Science (London)", "ISSN": "http://id.crossref.org/issn/1476-4687", "issn-type": "print"}], "container-title": ["Proceedings of the National Academy of Sciences"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1073/pnas.95.18.10860", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 6, 15]], "date-time": "2017-06-15T06:34:39Z", "timestamp": 1497508479000}, "score": 84.93262, "issued": {"date-parts": [[1998, 9, 1]]}, "references-count": 35, "journal-issue": {"published-print": {"date-parts": [[1998, 9, 1]]}, "issue": "18"}, "URL": "http://dx.doi.org/10.1073/pnas.95.18.10860", "relation": {"cites": []}, "ISSN": ["0027-8424", "1091-6490"], "issn-type": [{"value": "0027-8424", "type": "print"}, {"value": "1091-6490", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 30]], "date-time": "2019-11-30T10:40:14Z", "timestamp": 1575110414097}, "reference-count": 18, "publisher": "Elsevier BV", "issue": "4", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2004, 4, 1]], "date-time": "2004-04-01T00:00:00Z", "timestamp": 1080777600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia Research"], "published-print": {"date-parts": [[2004, 4]]}, "DOI": "10.1016/j.leukres.2003.08.016", "type": "journal-article", "created": {"date-parts": [[2003, 12, 4]], "date-time": "2003-12-04T12:02:13Z", "timestamp": 1070539333000}, "page": "409-414", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Domains involved in ETO and human N-CoR interaction and ETO transcription repression"], "prefix": "10.1016", "volume": "28", "author": [{"given": "Jianxiang", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "Min", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Johnson M", "family": "Liu", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Leukemia Research"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0145212603003059?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0145212603003059?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 16]], "date-time": "2019-02-16T14:22:08Z", "timestamp": 1550326928000}, "score": 49.213432, "issued": {"date-parts": [[2004, 4]]}, "references-count": 18, "journal-issue": {"published-print": {"date-parts": [[2004, 4]]}, "issue": "4"}, "alternative-id": ["S0145212603003059"], "URL": "http://dx.doi.org/10.1016/j.leukres.2003.08.016", "ISSN": ["0145-2126"], "issn-type": [{"value": "0145-2126", "type": "print"}], "subject": ["Cancer Research", "Oncology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T05:22:08Z", "timestamp": 1574832128472}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "9", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2016, 9, 1]], "date-time": "2016-09-01T00:00:00Z", "timestamp": 1472688000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Experimental Hematology"], "published-print": {"date-parts": [[2016, 9]]}, "DOI": "10.1016/j.exphem.2016.06.178", "type": "journal-article", "created": {"date-parts": [[2016, 8, 24]], "date-time": "2016-08-24T09:30:57Z", "timestamp": 1472031057000}, "page": "S87-S88", "source": "Crossref", "is-referenced-by-count": 0, "title": ["AML1/ETO represses the expression of a potential tumor suppressor, CST7, IN T(8;21) acute myeloid leukemia through DNA methylation"], "prefix": "10.1016", "volume": "44", "author": [{"given": "Yizhen", "family": "Li", "sequence": "first", "affiliation": []}, {"given": "Kankan", "family": "Wang", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Experimental Hematology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0301472X16303654?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0301472X16303654?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 9, 9]], "date-time": "2018-09-09T01:58:57Z", "timestamp": 1536458337000}, "score": 39.91085, "issued": {"date-parts": [[2016, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 9]]}, "issue": "9"}, "alternative-id": ["S0301472X16303654"], "URL": "http://dx.doi.org/10.1016/j.exphem.2016.06.178", "ISSN": ["0301-472X"], "issn-type": [{"value": "0301-472X", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:10:25Z", "timestamp": 1575529825640}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "21", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2010, 11, 19]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Abstract 3368</jats:p>\n               <jats:p>Translocation (8;21)(q22;q22) is the most common cytogenetic abnormality found in acute myeloid leukemia (AML), presenting in around 15% of all cases and is also reported in lymphoid leukemia. This subtype of AML has a favourable prognosis in contrast to other AML subtypes, however the mechanisms underlying this good response to treatment are not well understood. The translocation between AML1 (RUNX1) and the almost full-length ETO (RUNX1T1, MTG8) gene produces a 752 amino acid fusion protein and changes a transcriptional modulator essential for hematopoiesis into a constitutive repressor. When AML1/ETO (AE) is expressed in animal models, further mutations are required for the development of leukemia. AE has also been detected at a considerable frequency in the Guthrie cards of individuals who developed t(8;21) AML up to twelve years later, suggesting that AE+ hematopoietic precursor cells can remain latent for many years before transformation. AE+ cells have an activated p53 pathway, increased levels of p53 response genes and display an increased susceptibility to DNA damaging agents. AE also decreases the levels of DNA repair genes, including those involved in base-excision repair. This evidence predicts the existence of a pre-leukemic, AE-expressing hematopoietic precursor, which easily acquires additional mutations required for transformation, but that also responds well to treatment. There are multiple alternative forms of AE, the best described being AML1/ETO9a (AE9a), which codes for a truncated version of the protein lacking a significant proportion of ETO. AE9a has been found to be more leukemogenic than AE in mouse models by causing leukemia without the need for additional mutations.</jats:p>\n               <jats:p>Our investigation aims to test the effect of cellular expression of AE or AE9a on mutation, cell death and transformation following exposure to leukemogens and to identify co-operating mutations involved in t(8;21) AML. TK6 lymphoblastoid cells are heterozygous for the TK gene and when exposed to mutagens, can lose their one functional copy and become TK-/-. These mutants can then be selected for and quantified. TK6 were lentivirally transduced with vectors containing EGFP and either AE or AE9a. AE was cloned into the pHR-SINcPPT-SIEW lentiviral transfer vector and a similar AE9a construct acquired. Virus was produced utilising the 293T cell line and TK6 were transduced by a spinfection technique. Expression was confirmed by flow cytometry, western blotting and qRT-PCR. Single clonal populations were generated and fusion gene expression levels of 28% (AE) and 40% (AE9a) relative to AE expression in Kasumi-1 (a t(8;21) AML patient-derived cell line) were achieved.</jats:p>\n               <jats:p>We used these transduced cell line models to determine whether the presence of AE or AE9a affected cell viability and susceptibility to the acquisition of mutations. Spontaneous TK-/- mutants were first purged from the population by treatment with CHAT media. Two weeks post CHAT treatment, AE+ TK6 were shown to acquire a greater number of mutations than controls, both spontaneously and when exposed to doxorubicin (Figure 1). AE+ TK6 had a 2.2 fold higher background mutation frequency than controls, suggesting that AE promotes spontaneous acquisition of mutations. When treated with low-dose doxorubicin, AE+ TK6 had a 2\u20133 fold higher mutation frequency (3.5 \u00d7 10\u22125) in comparison to controls; wild-type TK6 and backbone transduced TK6 (1.4 \u00d7 10\u22125 and 1.1 \u00d7 10\u22125 respectively). High density SNP array analysis of AE-expressing TK6 has recently identified deletions at 10q25.1 and 3p24.3. The deletion at 3p24.3 potentially affects expression of SGOL1, coding for a protein involved in sister chromatid segregation and PCAF, an acetyl transferase which has been implicated in the regulation of p53. The effect of the deletion on these genes is currently being evaluated.</jats:p>\n               <jats:p>Figure 1. Mutation frequency of wild type TK6, backbone control and AE-expressing TK6 in response to doxorubicin. Figure 1. Mutation frequency of wild type TK6, backbone control and AE-expressing TK6 in response to doxorubicin.</jats:p>\n               <jats:p>Our data show that TK6 expressing AE or AE9a have an enhanced sensitivity to the cytotoxic effects of the anthracycline doxorubicin. This contributes to the understanding of the relatively good prognosis of t(8;21) AML. We have shown that expression of AE in a cell system promotes the acquisition of more mutations than that of non-expressing cells. This provides further understanding as to how the pre-leukemic AE+ hematopoetic clone transforms and results in leukemia.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosures:</jats:title>\n                  <jats:p>No relevant conflicts of interest to declare.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v116.21.3368.3368", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T12:51:41Z", "timestamp": 1570884701000}, "page": "3368-3368", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["The t(8;21) Fusion Protein AML1/ETO Promotes Susceptibility to Mutation In Acute Myeloid Leukemia."], "prefix": "10.1182", "volume": "116", "author": [{"given": "Victoria J", "family": "Forster", "sequence": "first", "affiliation": [{"name": "Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom"}]}, {"given": "James M.", "family": "Allan", "sequence": "additional", "affiliation": [{"name": "Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom"}]}, {"given": "Olaf", "family": "Heidenreich", "sequence": "additional", "affiliation": [{"name": "Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/116/21/3368/66013/The-t821-Fusion-Protein-AML1ETO-Promotes", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/116/21/3368/66013/The-t821-Fusion-Protein-AML1ETO-Promotes", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 16]], "date-time": "2019-11-16T12:03:27Z", "timestamp": 1573905807000}, "score": 37.381596, "issued": {"date-parts": [[2010, 11, 19]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2010, 11, 19]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1182/blood.v116.21.3368.3368", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T00:48:27Z", "timestamp": 1574470107820}, "reference-count": 51, "publisher": "Wiley", "issue": "5", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 1652, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Cell. Physiol."], "published-print": {"date-parts": [[2011, 5]]}, "DOI": "10.1002/jcp.22449", "type": "journal-article", "created": {"date-parts": [[2010, 10, 13]], "date-time": "2010-10-13T14:19:38Z", "timestamp": 1286979578000}, "page": "1232-1240", "source": "Crossref", "is-referenced-by-count": 4, "title": ["Oncoprotein Cot1 represses kinase suppressors of Ras1/2 and 1,25-dihydroxyvitamin D3-induced differentiation of human acute myeloid leukemia cells"], "prefix": "10.1002", "volume": "226", "author": [{"given": "Xuening", "family": "Wang", "sequence": "first", "affiliation": []}, {"given": "George P.", "family": "Studzinski", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2011, 2, 22]]}, "reference": [{"key": "10.1002/jcp.22449-BIB1|cit1", "doi-asserted-by": "crossref", "first-page": "4990", "DOI": "10.1073/pnas.78.8.4990", "article-title": "Differentiation of mouse myeloid leukemia cells induced by 1 alpha,25-dihydroxyvitamin D3", "volume": "78", "author": "Abe", "year": "1981", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/jcp.22449-BIB2|cit2", "doi-asserted-by": "crossref", "first-page": "569", "DOI": "10.1002/jcp.22240", "article-title": "The human SWI/SNF complex associates with RUNX1 to control transcription of hematopoietic target genes", "volume": "225", "author": "Bakshi", "year": "2010", "journal-title": "J Cell Physiol"}, {"key": "10.1002/jcp.22449-BIB3|cit3", "doi-asserted-by": "crossref", "first-page": "2431", "DOI": "10.1002/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.0.CO;2-3", "article-title": "A Phase I trial of pulse calcitriol in patients with refractory malignancies: Pulse dosing permits substantial dose escalation", "volume": "91", "author": "Beer", "year": "2001", "journal-title": "Cancer"}, {"key": "10.1002/jcp.22449-BIB4|cit4", "doi-asserted-by": "crossref", "first-page": "47089", "DOI": "10.1074/jbc.M306002200", "article-title": "Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling", "volume": "278", "author": "Channavajhala", "year": "2003", "journal-title": "J Biol Chem"}, {"key": "10.1002/jcp.22449-BIB5|cit5", "doi-asserted-by": "crossref", "first-page": "1214", "DOI": "10.1016/j.bbrc.2005.07.009", "article-title": "hKSR-2 inhibits MEKK3-activated MAP kinase and NF-kappaB pathways in inflammation", "volume": "334", "author": "Channavajhala", "year": "2005", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1002/jcp.22449-BIB6|cit6", "first-page": "2696", "article-title": "Rearrangements in the second intron of the RARA gene are present in a large majority of patients with acute promyelocytic leukemia and are used as molecular marker for retinoic acid-induced leukemic cell differentiation", "volume": "78", "author": "Chen", "year": "1991", "journal-title": "Blood"}, {"key": "10.1002/jcp.22449-BIB7|cit7", "doi-asserted-by": "crossref", "first-page": "1372", "DOI": "10.1016/j.leukres.2009.03.003", "article-title": "c-Jun N-terminal kinase 2 (JNK2) antagonizes the signaling of differentiation by JNK1 in human myeloid leukemia cells resistant to vitamin D", "volume": "33", "author": "Chen-Deutsch", "year": "2009", "journal-title": "Leuk Res"}, {"key": "10.1002/jcp.22449-BIB8|cit8", "doi-asserted-by": "crossref", "first-page": "1747", "DOI": "10.1128/MCB.20.5.1747-1758.2000", "article-title": "Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation", "volume": "20", "author": "Chiariello", "year": "2000", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/jcp.22449-BIB9|cit9", "doi-asserted-by": "crossref", "first-page": "339", "DOI": "10.1016/j.yexcr.2004.04.029", "article-title": "Enhancement by other compounds of the anti-cancer activity of vitamin D3 and its analogs", "volume": "298", "author": "Danilenko", "year": "2004", "journal-title": "Exp Cell Res"}, {"key": "10.1002/jcp.22449-BIB10|cit10", "doi-asserted-by": "crossref", "first-page": "1224", "DOI": "10.1093/jnci/93.16.1224", "article-title": "Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents", "volume": "93", "author": "Danilenko", "year": "2001", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/jcp.22449-BIB11|cit11", "doi-asserted-by": "crossref", "first-page": "23748", "DOI": "10.1074/jbc.M412837200", "article-title": "Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner", "volume": "280", "author": "Das", "year": "2005", "journal-title": "J Biol Chem"}, {"key": "10.1002/jcp.22449-BIB12|cit12", "doi-asserted-by": "crossref", "first-page": "7140", "DOI": "10.1038/sj.onc.1204763", "article-title": "All trans retinoic acid in acute promyelocytic leukemia", "volume": "20", "author": "Degos", "year": "2001", "journal-title": "Oncogene"}, {"key": "10.1002/jcp.22449-BIB13|cit13", "doi-asserted-by": "crossref", "first-page": "4125", "DOI": "10.1128/MCB.15.8.4125", "article-title": "Regulation of Raf-1 and Raf-1 mutants by Ras-dependent and Ras-independent mechanisms in vitro", "volume": "15", "author": "Dent", "year": "1995", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/jcp.22449-BIB14|cit14", "first-page": "713", "article-title": "Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia", "volume": "54", "author": "Gallagher", "year": "1979", "journal-title": "Blood"}, {"key": "10.1002/jcp.22449-BIB15|cit15", "first-page": "295", "article-title": "Mycoplasma detection in cell cultures: A comparison of four methods", "volume": "57", "author": "Garner", "year": "2000", "journal-title": "Br J Biomed Sci"}, {"key": "10.1002/jcp.22449-BIB16|cit16", "doi-asserted-by": "crossref", "first-page": "5288", "DOI": "10.1016/j.bmcl.2005.08.029", "article-title": "Inhibition of Tpl2 kinase and TNF-alpha production with 1,7-naphthyridine-3-carbonitriles: Synthesis and structure-activity relationships", "volume": "15", "author": "Gavrin", "year": "2005", "journal-title": "Bioorg Med Chem Lett"}, {"key": "10.1002/jcp.22449-BIB17|cit17", "doi-asserted-by": "crossref", "first-page": "190", "DOI": "10.1080/10408360902982128", "article-title": "Vitamin D and differentiation in cancer", "volume": "46", "author": "Gocek", "year": "2009", "journal-title": "Crit Rev Clin Lab Sci"}, {"key": "10.1002/jcp.22449-BIB18|cit18", "doi-asserted-by": "crossref", "first-page": "1391", "DOI": "10.1038/sj.onc.1202431", "article-title": "Cot protooncoprotein activates the dual specificity kinases MEK-1 and SEK-1 and induces differentiation of PC12 cells", "volume": "18", "author": "Hagemann", "year": "1999", "journal-title": "Oncogene"}, {"key": "10.1002/jcp.22449-BIB19|cit19", "doi-asserted-by": "crossref", "first-page": "133", "DOI": "10.1248/bpb.33.133", "article-title": "Inhibition of tumor progression locus 2 protein kinase suppresses receptor activator of nuclear factor-kappaB ligand-induced osteoclastogenesis through down-regulation of the c-Fos and nuclear factor of activated T cells c1 genes", "volume": "33", "author": "Hirata", "year": "2010", "journal-title": "Biol Pharm Bull"}, {"key": "10.1002/jcp.22449-BIB20|cit20", "doi-asserted-by": "crossref", "first-page": "917", "DOI": "10.4161/cc.7.7.5620", "article-title": "Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling", "volume": "7", "author": "Jamshidi", "year": "2008", "journal-title": "Cell Cycle"}, {"key": "10.1002/jcp.22449-BIB21|cit21", "doi-asserted-by": "crossref", "first-page": "370", "DOI": "10.1158/0008-5472.CAN-03-3029", "article-title": "Retinoblastoma protein and CCAAT/enhancer-binding protein beta are required for 1,25-dihydroxyvitamin D3-induced monocytic differentiation of HL60 cells", "volume": "64", "author": "Ji", "year": "2004", "journal-title": "Cancer Res"}, {"key": "10.1002/jcp.22449-BIB22|cit22", "first-page": "1399", "article-title": "1,25-Dihydroxyvitamin D3: In vivo and in vitro effects on human preleukemic and leukemic cells", "volume": "69", "author": "Koeffler", "year": "1985", "journal-title": "Cancer Treat Rep"}, {"key": "10.1002/jcp.22449-BIB23|cit23", "doi-asserted-by": "crossref", "first-page": "827", "DOI": "10.1038/nrm1743", "article-title": "Coordinating ERK/MAPK signalling through scaffolds and inhibitors", "volume": "6", "author": "Kolch", "year": "2005", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "10.1002/jcp.22449-BIB24|cit24", "doi-asserted-by": "crossref", "first-page": "2349", "DOI": "10.1001/jama.2009.813", "article-title": "Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: Systematic review and meta-analysis of prospective clinical trials", "volume": "301", "author": "Koreth", "year": "2009", "journal-title": "JAMA"}, {"key": "10.1002/jcp.22449-BIB25|cit25", "first-page": "101", "article-title": "Control of the ERK MAP kinase cascade by Ras and Raf", "volume": "27", "author": "Marais", "year": "1996", "journal-title": "Cancer Surv"}, {"key": "10.1002/jcp.22449-BIB26|cit26", "doi-asserted-by": "crossref", "first-page": "419", "DOI": "10.1006/bbrc.1997.7832", "article-title": "1,25-Dihydroxyvitamin D3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells", "volume": "241", "author": "Marcinkowska", "year": "1997", "journal-title": "Biochem Biophys Res Commun"}, {"key": "10.1002/jcp.22449-BIB27|cit27", "doi-asserted-by": "crossref", "first-page": "2054", "DOI": "10.1016/j.yexcr.2006.03.003", "article-title": "Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3", "volume": "312", "author": "Marcinkowska", "year": "2006", "journal-title": "Exp Cell Res"}, {"key": "10.1002/jcp.22449-BIB28|cit28", "doi-asserted-by": "crossref", "first-page": "4088", "DOI": "10.1128/MCB.11.8.4088", "article-title": "Structure and transforming potential of the human cot oncogene encoding a putative protein kinase", "volume": "11", "author": "Miyoshi", "year": "1991", "journal-title": "Mol Cell Biol"}, {"key": "10.1002/jcp.22449-BIB29|cit29", "doi-asserted-by": "crossref", "first-page": "45", "DOI": "10.1016/S0145-2126(96)00089-6", "article-title": "Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with a t(8;21) chromosome translocation", "volume": "21", "author": "Miyoshi", "year": "1997", "journal-title": "Leuk Res"}, {"key": "10.1002/jcp.22449-BIB30|cit30", "doi-asserted-by": "crossref", "first-page": "424", "DOI": "10.1172/JCI112593", "article-title": "Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells", "volume": "78", "author": "Munker", "year": "1986", "journal-title": "J Clin Invest"}, {"key": "10.1002/jcp.22449-BIB31|cit31", "doi-asserted-by": "crossref", "first-page": "2251", "DOI": "10.1073/pnas.90.6.2251", "article-title": "Tumor progression locus 2 (Tpl-2) encodes a protein kinase involved in the progression of rodent T-cell lymphomas and in T-cell activation", "volume": "90", "author": "Patriotis", "year": "1993", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/jcp.22449-BIB32|cit32", "doi-asserted-by": "crossref", "first-page": "817", "DOI": "10.1002/j.1460-2075.1996.tb00417.x", "article-title": "Activation of MEK-1 and SEK-1 by Tpl-2 proto-oncoprotein, a novel MAP kinase kinase kinase", "volume": "15", "author": "Salmeron", "year": "1996", "journal-title": "EMBO J"}, {"key": "10.1002/jcp.22449-BIB33|cit33", "doi-asserted-by": "crossref", "first-page": "1798", "DOI": "10.1038/sj.leu.2403528", "article-title": "Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia", "volume": "18", "author": "Schlenk", "year": "2004", "journal-title": "Leukemia"}, {"key": "10.1002/jcp.22449-BIB34|cit34", "doi-asserted-by": "crossref", "first-page": "203", "DOI": "10.1159/000163849", "article-title": "Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia", "volume": "75", "author": "Shabtay", "year": "2008", "journal-title": "Oncology"}, {"key": "10.1002/jcp.22449-BIB35|cit35", "doi-asserted-by": "crossref", "first-page": "3012", "DOI": "10.1002/ijc.21736", "article-title": "Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemia", "volume": "118", "author": "Sharabani", "year": "2006", "journal-title": "Int J Cancer"}, {"key": "10.1002/jcp.22449-BIB36|cit36", "doi-asserted-by": "crossref", "first-page": "288", "DOI": "10.3181/00379727-179-42098", "article-title": "A system for monocytic differentiation of leukemic cells HL 60 by a short exposure to 1,25-dihydroxycholecalciferol", "volume": "179", "author": "Studzinski", "year": "1985", "journal-title": "Proc Soc Exp Biol Med"}, {"key": "10.1002/jcp.22449-BIB37|cit37", "doi-asserted-by": "crossref", "first-page": "47", "DOI": "10.1016/j.jsbmb.2005.06.010", "article-title": "The rationale for deltanoids in therapy for myeloid leukemia: Role of KSR-MAPK-C/EBP pathway", "volume": "97", "author": "Studzinski", "year": "2005", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "10.1002/jcp.22449-BIB38|cit38", "doi-asserted-by": "crossref", "first-page": "565", "DOI": "10.1002/ijc.2910170504", "article-title": "Establishment and characterization of a human histiocytic lymphoma cell line (U-937)", "volume": "17", "author": "Sundstrom", "year": "1976", "journal-title": "Int J Cancer"}, {"key": "10.1002/jcp.22449-BIB39|cit39", "doi-asserted-by": "crossref", "first-page": "759", "DOI": "10.1182/blood.V99.3.759", "article-title": "Acute promyelocytic leukemia: Evolving therapeutic strategies", "volume": "99", "author": "Tallman", "year": "2002", "journal-title": "Blood"}, {"key": "10.1002/jcp.22449-BIB40|cit40", "doi-asserted-by": "crossref", "first-page": "713", "DOI": "10.1042/bj2040713", "article-title": "1 alpha,25-Dihydroxycholecalciferol and a human myeloid leukaemia cell line (HL-60)", "volume": "204", "author": "Tanaka", "year": "1982", "journal-title": "Biochem J"}, {"key": "10.1002/jcp.22449-BIB41|cit41", "doi-asserted-by": "crossref", "first-page": "471", "DOI": "10.1002/1097-4644(20010315)80:4<471::AID-JCB1001>3.0.CO;2-J", "article-title": "Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells", "volume": "80", "author": "Wang", "year": "2001", "journal-title": "J Cell Biochem"}, {"key": "10.1002/jcp.22449-BIB42|cit42", "doi-asserted-by": "crossref", "first-page": "333", "DOI": "10.1002/jcp.10443", "article-title": "Kinase suppressor of RAS (KSR) amplifies the differentiation signal provided by low concentrations 1,25-dihydroxyvitamin D3", "volume": "198", "author": "Wang", "year": "2004", "journal-title": "J Cell Physiol"}, {"key": "10.1002/jcp.22449-BIB43|cit43", "doi-asserted-by": "crossref", "first-page": "253", "DOI": "10.1002/jcp.20731", "article-title": "Raf-1 signaling is required for the later stages of 1,25-dihydroxyvitamin D3-induced differentiation of HL60 cells but is not mediated by the MEK/ERK module", "volume": "209", "author": "Wang", "year": "2006", "journal-title": "J Cell Physiol"}, {"key": "10.1002/jcp.22449-BIB44|cit44", "doi-asserted-by": "crossref", "first-page": "395", "DOI": "10.1016/j.jsbmb.2010.03.016", "article-title": "Expression of MAP3 kinase COT1 is up-regulated by 1,25-dihydroxyvitamin D3 in parallel with activated c-jun during differentiation of human myeloid leukemia cells", "volume": "121", "author": "Wang", "year": "2010", "journal-title": "J Steroid Biochem Mol Biol"}, {"key": "10.1002/jcp.22449-BIB45|cit45", "doi-asserted-by": "crossref", "first-page": "1199", "DOI": "10.1093/jnci/89.16.1199", "article-title": "Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3", "volume": "89", "author": "Wang", "year": "1997", "journal-title": "J Natl Cancer Inst"}, {"key": "10.1002/jcp.22449-BIB46|cit46", "doi-asserted-by": "crossref", "first-page": "425", "DOI": "10.1006/excr.2000.4939", "article-title": "Inhibition of p38 MAP kinase activity up-regulates multiple MAP kinase pathways and potentiates 1,25-dihydroxyvitamin D3-induced differentiation of human leukemia HL60 cells", "volume": "258", "author": "Wang", "year": "2000", "journal-title": "Exp Cell Res"}, {"key": "10.1002/jcp.22449-BIB47|cit47", "doi-asserted-by": "crossref", "first-page": "1087", "DOI": "10.1002/jcb.10595", "article-title": "Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3", "volume": "89", "author": "Wang", "year": "2003", "journal-title": "J Cell Biochem"}, {"key": "10.1002/jcp.22449-BIB48|cit48", "doi-asserted-by": "crossref", "first-page": "7078", "DOI": "10.1038/sj.onc.1209697", "article-title": "Induction of kinase suppressor of RAS-1(KSR-1) gene by 1, alpha25-dihydroxyvitamin D3 in human leukemia HL60 cells through a vitamin D response element in the 5\u2032-flanking region", "volume": "25", "author": "Wang", "year": "2006", "journal-title": "Oncogene"}, {"key": "10.1002/jcp.22449-BIB49|cit49", "doi-asserted-by": "crossref", "first-page": "3034", "DOI": "10.1016/j.yexcr.2007.05.021", "article-title": "Expression of human kinase suppressor of Ras 2 (hKSR-2) gene in HL60 leukemia cells is directly upregulated by 1,25-dihydroxyvitamin D3 and is required for optimal cell differentiation", "volume": "313", "author": "Wang", "year": "2007", "journal-title": "Exp Cell Res"}, {"key": "10.1002/jcp.22449-BIB50|cit50", "first-page": "124", "article-title": "Silibinin can induce differentiation as well as enhance vitamin D3-induced differentiation of human AML cells ex vivo and regulates the levels of differentiation-related transcription factors", "volume": "28", "author": "Zhang", "year": "2010a", "journal-title": "Hematol Oncol"}, {"key": "10.1002/jcp.22449-BIB51|cit51", "author": "Zhang", "year": "2010b", "article-title": "Isoforms of p38MAPK gamma and delta contribute to differentiation of human AML cells induced by 1,25-dihydroxyvitamin D3", "journal-title": "Exp Cell Res"}], "container-title": ["Journal of Cellular Physiology"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcp.22449", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 6, 5]], "date-time": "2019-06-05T12:31:28Z", "timestamp": 1559737888000}, "score": 34.579247, "issued": {"date-parts": [[2011, 2, 22]]}, "references-count": 51, "journal-issue": {"published-print": {"date-parts": [[2011, 5]]}, "issue": "5"}, "URL": "http://dx.doi.org/10.1002/jcp.22449", "relation": {"cites": []}, "ISSN": ["0021-9541"], "issn-type": [{"value": "0021-9541", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T17:52:30Z", "timestamp": 1574272350282}, "reference-count": 8, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 2, 8]], "date-time": "2007-02-08T00:00:00Z", "timestamp": 1170892800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2007, 4]]}, "DOI": "10.1038/sj.leu.2404579", "type": "journal-article", "created": {"date-parts": [[2007, 2, 8]], "date-time": "2007-02-08T12:24:01Z", "timestamp": 1170937441000}, "page": "842-844", "source": "Crossref", "is-referenced-by-count": 37, "title": ["A novel NUP98-PHF23 fusion resulting from a cryptic translocation t(11;17)(p15;p13) in acute myeloid leukemia"], "prefix": "10.1038", "volume": "21", "author": [{"given": "J C", "family": "Reader", "sequence": "first", "affiliation": []}, {"given": "J S", "family": "Meekins", "sequence": "additional", "affiliation": []}, {"given": "I", "family": "Gojo", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Ning", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 2, 8]]}, "reference": [{"key": "BF2404579_CR1", "doi-asserted-by": "publisher", "first-page": "1341", "DOI": "10.1080/10428190310001659325", "volume": "45", "author": "C Slape", "year": "2004", "unstructured": "Slape C, Aplan PD . The role of NUP98 gene fusions in hematologic malignancy. Leuk Lymphoma 2004; 45: 1341\u20131350.", "journal-title": "Leuk Lymphoma"}, {"key": "BF2404579_CR2", "doi-asserted-by": "publisher", "first-page": "86", "DOI": "10.1038/nature04815", "volume": "442", "author": "J Wysocka", "year": "2006", "unstructured": "Wysocka J, Swigut T, Xiao H, Milne TA, Kwon SY, Landry J et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006; 442: 86\u201390.", "journal-title": "Nature"}, {"key": "BF2404579_CR3", "doi-asserted-by": "publisher", "first-page": "96", "DOI": "10.1038/nature04835", "volume": "442", "author": "X Shi", "year": "2006", "unstructured": "Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T et al. ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 2006; 442: 96\u201399.", "journal-title": "Nature"}, {"key": "BF2404579_CR4", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1097/01.moh.0000208467.63861.d6", "volume": "13", "author": "EA Eklund", "year": "2006", "unstructured": "Eklund EA . The role of HOX genes in myeloid leukemogenesis. Curr Opin Hematol 2006; 13: 67\u201373.", "journal-title": "Curr Opin Hematol"}, {"key": "BF2404579_CR5", "doi-asserted-by": "publisher", "first-page": "1097", "DOI": "10.1182/blood.V99.3.1097", "volume": "99", "author": "DJ Hussey", "year": "2002", "unstructured": "Hussey DJ, Dobrovic A . Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis. Blood 2002; 99: 1097\u20131098.", "journal-title": "Blood"}, {"key": "BF2404579_CR6", "doi-asserted-by": "publisher", "first-page": "1264", "DOI": "10.1182/blood.V98.4.1264", "volume": "98", "author": "RJ Jaju", "year": "2001", "unstructured": "Jaju RJ, Fidler C, Haas OA, Strickson AJ, Watkins F, Clark K et al. A novel gene, NSD1, is fused to NUP98 in the t(5;11)(q35;p15*5) in de novo childhood acute myeloid leukemia. Blood 2001; 98: 1264\u20131267.", "journal-title": "Blood"}, {"key": "BF2404579_CR7", "doi-asserted-by": "publisher", "first-page": "3857", "DOI": "10.1182/blood.V99.10.3857", "volume": "99", "author": "R Rosati", "year": "2002", "unstructured": "Rosati R, La Starza R, Veronese A, Aventin A, Schwienbacher C, Vallespi T et al. NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15). Blood 2002; 99: 3857\u20133860.", "journal-title": "Blood"}, {"key": "BF2404579_CR8", "doi-asserted-by": "publisher", "first-page": "1127", "DOI": "10.1182/blood-2003-10-3550", "volume": "104", "author": "RM Gurevich", "year": "2004", "unstructured": "Gurevich RM, Aplan PD, Humphries RK . NUP98-topoisomerase I acute myeloid leukemia-associated fusion gene has potent leukemogenic activities independent of an engineered catalytic site mutation. Blood 2004; 104: 1127\u20131136.", "journal-title": "Blood"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2404579.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404579", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404579.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T14:06:25Z", "timestamp": 1555596385000}, "score": 33.4588, "issued": {"date-parts": [[2007, 2, 8]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2007, 4]]}, "issue": "4"}, "alternative-id": ["BF2404579"], "URL": "http://dx.doi.org/10.1038/sj.leu.2404579", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:55:10Z", "timestamp": 1574135710912}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "10", "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2002, 5, 15]]}, "DOI": "10.1182/blood.v99.10.3801", "type": "journal-article", "created": {"date-parts": [[2002, 10, 1]], "date-time": "2002-10-01T21:48:18Z", "timestamp": 1033508898000}, "page": "3801-3805", "source": "Crossref", "is-referenced-by-count": 157, "title": ["In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia"], "prefix": "10.1182", "volume": "99", "author": [{"given": "J. L.", "family": "Wiemels", "sequence": "first", "affiliation": []}], "member": "234", "container-title": ["Blood"], "deposited": {"date-parts": [[2011, 7, 19]], "date-time": "2011-07-19T09:09:05Z", "timestamp": 1311066545000}, "score": 33.18795, "issued": {"date-parts": [[2002, 5, 15]]}, "references-count": 0, "journal-issue": {"issue": "10"}, "URL": "http://dx.doi.org/10.1182/blood.v99.10.3801", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:31:13Z", "timestamp": 1575178273496}, "reference-count": 8, "publisher": "Springer Science and Business Media LLC", "issue": "12", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 9, 29]], "date-time": "2005-09-29T00:00:00Z", "timestamp": 1127952000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2005, 12]]}, "DOI": "10.1038/sj.leu.2403971", "type": "journal-article", "created": {"date-parts": [[2005, 9, 29]], "date-time": "2005-09-29T11:49:02Z", "timestamp": 1127994542000}, "page": "2344-2345", "source": "Crossref", "is-referenced-by-count": 12, "title": ["Detection of MOZ-CBP fusion in acute myeloid leukemia with 8;16 translocation"], "prefix": "10.1038", "volume": "19", "author": [{"given": "J A", "family": "Crowley", "sequence": "first", "affiliation": []}, {"given": "Y", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "A P", "family": "Rapoport", "sequence": "additional", "affiliation": []}, {"given": "Y", "family": "Ning", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 9, 29]]}, "reference": [{"key": "BF2403971_CR1", "doi-asserted-by": "publisher", "first-page": "207", "DOI": "10.1002/1096-8652(200103)66:3<207::AID-AJH1046>3.0.CO;2-Q", "volume": "66", "author": "T Sun", "year": "2001", "unstructured": "Sun T, Wu E . Acute monoblastic leukemia with t(8;16): a distinct clinicopathologic entity; report of a case and review of the literature. Am J Hematol 2001; 66: 207\u2013212.", "journal-title": "Am J Hematol"}, {"key": "BF2403971_CR2", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1038/ng0996-33", "volume": "14", "author": "J Borrow", "year": "1996", "unstructured": "Borrow J, Stanton Jr VP, Andresen JM, Becher R, Behm FG, Chaganti RS et al. The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein. Nat Genet 1996; 14: 33\u201341.", "journal-title": "Nat Genet"}, {"key": "BF2403971_CR3", "doi-asserted-by": "publisher", "first-page": "2087", "DOI": "10.1038/sj.leu.2400882", "volume": "11", "author": "RH Giles", "year": "1997", "unstructured": "Giles RH, Dauwerse JG, Higgins C, Petrij F, Wessels JW, Beverstock GC et al. Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16). Leukemia 1997; 11: 2087\u20132096.", "journal-title": "Leukemia"}, {"key": "BF2403971_CR4", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1002/(SICI)1098-2264(199910)26:2<161::AID-GCC8>3.0.CO;2-6", "volume": "26", "author": "M Chaffanet", "year": "1999", "unstructured": "Chaffanet M, Mozziconacci MJ, Fernandez F, Sainty D, Lafage-Pochitaloff M, Birnbaum D et al. A case of inv(8)(p11q24) associated with acute myeloid leukemia involves the MOZ and CBP genes in a masked t(8;16). Genes Chromosomes Cancer 1999; 26: 161\u2013165.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2403971_CR5", "doi-asserted-by": "publisher", "first-page": "1115", "DOI": "10.1038/sj.leu.2403353", "volume": "18", "author": "HH Schmidt", "year": "2004", "unstructured": "Schmidt HH, Strehl S, Thaler D, Strunk D, Sill H, Linkesch W et al. RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications. Leukemia 2004; 18: 1115\u20131121.", "journal-title": "Leukemia"}, {"key": "BF2403971_CR6", "doi-asserted-by": "publisher", "first-page": "78", "DOI": "10.1016/j.cancergencyto.2004.06.008", "volume": "157", "author": "JA Crowley", "year": "2005", "unstructured": "Crowley JA, Butler MS, Ronnenburg MJ, Ament CN, Meekins JS, Ning Y . Development of a dual-color fluorescence in situ hybridization probe set on chromosome 6q to improve cytogenetic diagnosis of lymphoid malignancies. Cancer Genet Cytogenet 2005; 157: 78\u201381.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2403971_CR7", "doi-asserted-by": "publisher", "first-page": "415", "DOI": "10.1002/1098-2264(200008)28:4<415::AID-GCC7>3.0.CO;2-I", "volume": "28", "author": "I Panagopoulos", "year": "2000", "unstructured": "Panagopoulos I, Isaksson M, Lindvall C, Bjorkholm M, Ahlgren T, Fioretos T et al. RT-PCR analysis of the MOZ-CBP and CBP-MOZ chimeric transcripts in acute myeloid leukemias with t(8;16)(p11;p13). Genes Chromosomes Cancer 2000; 28: 415\u2013424.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2403971_CR8", "doi-asserted-by": "publisher", "first-page": "140", "DOI": "10.1002/gcc.20022", "volume": "40", "author": "M Rozman", "year": "2004", "unstructured": "Rozman M, Camos M, Colomer D, Villamor N, Esteve J, Costa D et al. Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation. Genes Chromosomes Cancer 2004; 40: 140\u2013145.", "journal-title": "Genes Chromosomes Cancer"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2403971.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403971", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2403971.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T06:04:16Z", "timestamp": 1553666656000}, "score": 32.218307, "issued": {"date-parts": [[2005, 9, 29]]}, "references-count": 8, "journal-issue": {"published-print": {"date-parts": [[2005, 12]]}, "issue": "12"}, "alternative-id": ["BF2403971"], "URL": "http://dx.doi.org/10.1038/sj.leu.2403971", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "subject": ["Anesthesiology and Pain Medicine", "Cancer Research", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T11:37:27Z", "timestamp": 1574163447482}, "reference-count": 42, "publisher": "Springer Science and Business Media LLC", "issue": "6", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2003, 5, 23]], "date-time": "2003-05-23T00:00:00Z", "timestamp": 1053648000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2003, 6]]}, "DOI": "10.1038/sj.leu.2402959", "type": "journal-article", "created": {"date-parts": [[2003, 5, 23]], "date-time": "2003-05-23T09:33:03Z", "timestamp": 1053682383000}, "page": "1130-1136", "source": "Crossref", "is-referenced-by-count": 55, "title": ["Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement"], "prefix": "10.1038", "volume": "17", "author": [{"given": "S", "family": "Viehmann", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Teigler-Schlegel", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Bruch", "sequence": "additional", "affiliation": []}, {"given": "C", "family": "Langebrake", "sequence": "additional", "affiliation": []}, {"given": "D", "family": "Reinhardt", "sequence": "additional", "affiliation": []}, {"given": "J", "family": "Harbott", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2003, 5, 23]]}, "reference": [{"key": "BF2402959_CR1", "first-page": "1825", "volume": "80", "author": "P Erickson", "year": "1992", "unstructured": "Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S et al. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 1992; 80: 1825\u20131831.", "journal-title": "Blood"}, {"key": "BF2402959_CR2", "doi-asserted-by": "publisher", "first-page": "2715", "DOI": "10.1002/j.1460-2075.1993.tb05933.x", "volume": "12", "author": "H Miyoshi", "year": "1993", "unstructured": "Miyoshi H, Kozu T, Shimizu K, Enomoto K, Maseki N, Kaneko Y et al. The t(8;21) translocation in acute myeloid leukemia results in production of an AML1-MTG8 fusion transcript. EMBO J 1993; 12: 2715\u20132721.", "journal-title": "EMBO J"}, {"key": "BF2402959_CR3", "doi-asserted-by": "publisher", "first-page": "103", "DOI": "10.1016/S0378-1119(98)00141-3", "volume": "212", "author": "JK Wolford", "year": "1998", "unstructured": "Wolford JK, Prochazka M . Structure and expression of the human MTG8/ETO gene. Gene 1998; 212: 103\u2013109.", "journal-title": "Gene"}, {"key": "BF2402959_CR4", "first-page": "592", "volume": "81", "author": "JE Tighe", "year": "1993", "unstructured": "Tighe JE, Daga A, Calabi F . Translocation breakpoints are clustered on both chromosome 8 and chromosome 21 in the t(8;21) of acute myeloid leukemia. Blood 1993; 81: 592\u2013596.", "journal-title": "Blood"}, {"key": "BF2402959_CR5", "first-page": "1270", "volume": "82", "author": "T Kozu", "year": "1993", "unstructured": "Kozu T, Miyoshi H, Shimizu K, Maseki N, Kaneko Y, Asou H et al. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction. Blood 1993; 82: 1270\u20131276.", "journal-title": "Blood"}, {"key": "BF2402959_CR6", "doi-asserted-by": "publisher", "first-page": "1901", "DOI": "10.1038/sj.leu.2401592", "volume": "13", "author": "JJ van Dongen", "year": "1999", "unstructured": "van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999; 13: 1901\u20131928.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR7", "first-page": "1139", "volume": "10", "author": "MJ Saunders", "year": "1996", "unstructured": "Saunders MJ, Tobal K, Keeney S, Liu YJ . Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8;21) irrespective of disease phase. Leukemia 1996; 10: 1139\u20131142.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR8", "first-page": "1780", "volume": "8", "author": "LT van de Locht", "year": "1994", "unstructured": "van de Locht LT, Smetsers TF, Wittebol S, Raymakers RA, Mensink EJ . Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia. Leukemia 1994; 8: 1780\u20131784.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR9", "first-page": "2115", "volume": "84", "author": "JE Tighe", "year": "1994", "unstructured": "Tighe JE, Calabi F . Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative (8) chromosome in the t(8;21) of acute myeloid leukemia M2. Blood 1994; 84: 2115\u20132121.", "journal-title": "Blood"}, {"key": "BF2402959_CR10", "first-page": "2322", "volume": "92", "author": "D Grimwade", "year": "1998", "unstructured": "Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322\u20132333.", "journal-title": "Blood"}, {"key": "BF2402959_CR11", "doi-asserted-by": "publisher", "first-page": "139", "DOI": "10.1016/0165-4608(94)90166-X", "volume": "75", "author": "M Gallego", "year": "1994", "unstructured": "Gallego M, Carroll AJ, Gad GS, Pappo A, Head D, Behm F et al. Variant t(8;21) rearrangements in acute myeloblastic leukemia of childhood. Cancer Genet Cytogenet 1994; 75: 139\u2013144.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2402959_CR12", "doi-asserted-by": "publisher", "first-page": "855", "DOI": "10.1046/j.1365-2141.1996.415954.x", "volume": "92", "author": "V Andrieu", "year": "1996", "unstructured": "Andrieu V, Radford-Weiss I, Troussard X, Chane C, Valensi F, Guesnu M et al. Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype. Br J Haematol 1996; 92: 855\u2013865.", "journal-title": "Br J Haematol"}, {"key": "BF2402959_CR13", "first-page": "2183", "volume": "88", "author": "J Jurlander", "year": "1996", "unstructured": "Jurlander J, Caligiuri MA, Ruutu T, Baer MR, Strout MP, Oberkircher AR et al. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 1996; 88: 2183\u20132191.", "journal-title": "Blood"}, {"key": "BF2402959_CR14", "first-page": "735", "volume": "8", "author": "R Kusec", "year": "1994", "unstructured": "Kusec R, Laczika K, Knobl P, Friedl J, Greinix H, Kahls P et al. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8: 735\u2013739.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR15", "first-page": "712", "volume": "82", "author": "G Nucifora", "year": "1993", "unstructured": "Nucifora G, Larson RA, Rowley JD . Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712\u2013715.", "journal-title": "Blood"}, {"key": "BF2402959_CR16", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.3109/10428199709109169", "volume": "26", "author": "N Sakata", "year": "1997", "unstructured": "Sakata N, Okamura T, Inoue M, Yumura-Yagi K, Hara J, Tawa A et al. Rapid disappearance of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia following bone marrow transplantation and chemotherapy. Leukemia Lymphoma 1997; 26: 141\u2013152.", "journal-title": "Leukemia Lymphoma"}, {"key": "BF2402959_CR17", "doi-asserted-by": "publisher", "first-page": "892", "DOI": "10.1111/j.1365-2141.1995.tb05406.x", "volume": "91", "author": "N Satake", "year": "1995", "unstructured": "Satake N, Maseki N, Kozu T, Sakashita A, Kobayashi H, Sakurai M et al. Disappearance of AML1-MTG8 (ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission. Br J Haematol 1995; 91: 892\u2013898.", "journal-title": "Br J Haematol"}, {"key": "BF2402959_CR18", "first-page": "186", "volume": "10", "author": "C Preudhomme", "year": "1996", "unstructured": "Preudhomme C, Philippe N, Macintyre E, Henic N, Lai JL, Jouet JP et al. Persistence of AML1/ETO fusion mRNA in t(8;21) acute myeloid leukemia (AML) in prolonged remission: is there a consensus? [letter]. Leukemia 1996; 10: 186\u2013188.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR19", "doi-asserted-by": "publisher", "first-page": "788", "DOI": "10.1200/JCO.2000.18.4.788", "volume": "18", "author": "F Morschhauser", "year": "2000", "unstructured": "Morschhauser F, Cayuela JM, Martini S, Baruchel A, Rousselot P, Socie G et al. Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients. J Clin Oncol 2000; 18: 788\u2013794.", "journal-title": "J Clin Oncol"}, {"key": "BF2402959_CR20", "doi-asserted-by": "publisher", "first-page": "85", "DOI": "10.1046/j.1365-2141.1996.d01-1877.x", "volume": "95", "author": "A Muto", "year": "1996", "unstructured": "Muto A, Mori S, Matsushita H, Awaya N, Ueno H, Takayama N et al. Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay. Br J Haematol 1996; 95: 85\u201394.", "journal-title": "Br J Haematol"}, {"key": "BF2402959_CR21", "first-page": "815", "volume": "95", "author": "K Tobal", "year": "2000", "unstructured": "Tobal K, Newton J, Macheta M, Chang J, Morgenstem G, Evans PA et al. Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapse. Blood 2000; 95: 815\u2013819.", "journal-title": "Blood"}, {"key": "BF2402959_CR22", "first-page": "3704", "volume": "88", "author": "K Tobal", "year": "1996", "unstructured": "Tobal K, Yin JA . Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8; 21). Blood 1996; 88: 3704\u20133709.", "journal-title": "Blood"}, {"key": "BF2402959_CR23", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1038/sj.leu.2401679", "volume": "14", "author": "MP Wattjes", "year": "2000", "unstructured": "Wattjes MP, Krauter J, Nagel S, Heidenreich O, Ganser A, Heil G . Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia. Leukemia 2000; 14: 329\u2013335.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR24", "doi-asserted-by": "publisher", "first-page": "951", "DOI": "10.1016/S0145-2126(00)00071-0", "volume": "24", "author": "M Kondo", "year": "2000", "unstructured": "Kondo M, Kudo K, Kimura H, Inaba J, Kato K, Kojima S et al. Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia. Leukemia Res 2000; 24: 951\u2013956.", "journal-title": "Leukemia Res"}, {"key": "BF2402959_CR25", "doi-asserted-by": "publisher", "first-page": "2705", "DOI": "10.1200/JCO.2001.19.10.2705", "volume": "19", "author": "U Creutzig", "year": "2001", "unstructured": "Creutzig U, Ritter J, Zimmermann M, Reinhardt D, Hermann J, Berthold F et al. Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin\u2013Frankfurt\u2013Munster 93. J Clin Oncol 2001; 19: 2705\u20132713.", "journal-title": "J Clin Oncol"}, {"key": "BF2402959_CR26", "first-page": "40", "volume": "8", "author": "F Maruyama", "year": "1994", "unstructured": "Maruyama F, Stass SA, Estey EH, Cork A, Hirano M, Ino T et al. Detection of AML1/ETO fusion transcript as a tool for diagnosing t(8;21) positive acute myelogenous leukemia. Leukemia 1994; 8: 40\u201345.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR27", "first-page": "1549", "volume": "87", "author": "A Hochhaus", "year": "1996", "unstructured": "Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van RF et al. Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction. Blood 1996; 87: 1549\u20131555.", "journal-title": "Blood"}, {"key": "BF2402959_CR28", "unstructured": "Beillard E, Pallisgaard N, Bi W, van der Velden V, Dee R, van der Schoot E et al. Evaluation of candidate control genes for diagnosis and MRD detection in leukemic patients using \u2018real-time\u2019 quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) \u2013 A Europe Against Cancer Program. Leukemia (in press)."}, {"key": "BF2402959_CR29", "first-page": "2031", "volume": "77", "author": "H Asou", "year": "1991", "unstructured": "Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N . Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031\u20132036.", "journal-title": "Blood"}, {"key": "BF2402959_CR30", "unstructured": "Drexler HG, Dirks W, MacLeod RAF, Quentmeier H, Steube K, Uphoff CC . Human and animal cell lines. DSMZ Cat 1997, 6th edn, pp 75--84."}, {"key": "BF2402959_CR31", "unstructured": "Gabert J, Beillard E, van der Velden V, Bi W, Grimwade D, Pallisgaard N et al. Standardization and quality control studies of \u2018real-time\u2019 quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) of fusion gene transcripts for residual disease detection in leukemia \u2013 A Europe Against Cancer Program. Leukemia (in press)."}, {"key": "BF2402959_CR32", "first-page": "1486", "volume": "94", "author": "T Lion", "year": "1999", "unstructured": "Lion T . Monitoring of residual disease in chronic myelogenous leukemia by quantitative polymerase chain reaction and clinical decision making. Blood 1999; 94: 1486\u20131488.", "journal-title": "Blood"}, {"key": "BF2402959_CR33", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1002/(SICI)1096-8652(200006)64:2<101::AID-AJH5>3.0.CO;2-X", "volume": "64", "author": "T Sugimoto", "year": "2000", "unstructured": "Sugimoto T, Das H, Imoto S, Murayama T, Gomyo H, Chakraborty S et al. Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR. Am J Hematol 2000; 64: 101\u2013106.", "journal-title": "Am J Hematol"}, {"key": "BF2402959_CR34", "doi-asserted-by": "publisher", "first-page": "252", "DOI": "10.1034/j.1600-0609.2000.90091.x", "volume": "64", "author": "S Fujimaki", "year": "2000", "unstructured": "Fujimaki S, Funato T, Harigae H, Imaizumi M, Suzuki H, Kaneko Y et al. A quantitative reverse transcriptase polymerase chain reaction method for the detection of leukaemic cells with t(8;21) in peripheral blood. Eur J Haematol 2000; 64: 252\u2013258.", "journal-title": "Eur J Haematol"}, {"key": "BF2402959_CR35", "doi-asserted-by": "publisher", "first-page": "80", "DOI": "10.1046/j.1365-2141.1999.01674.x", "volume": "107", "author": "J Krauter", "year": "1999", "unstructured": "Krauter J, Wattjes MP, Nagel S, Heidenreich O, Krug U, Kafert S et al. Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients. Br J Haematol 1999; 107: 80\u201385.", "journal-title": "Br J Haematol"}, {"key": "BF2402959_CR36", "doi-asserted-by": "publisher", "first-page": "1482", "DOI": "10.1038/sj.leu.2401128", "volume": "12", "author": "G Marcucci", "year": "1998", "unstructured": "Marcucci G, Livak KJ, Bi W, Strout MP, Bloomfield CD, Caligiuri MA . Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia 1998; 12: 1482\u20131489.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR37", "doi-asserted-by": "publisher", "first-page": "747", "DOI": "10.3109/10428190109099337", "volume": "42", "author": "E Barragan", "year": "2001", "unstructured": "Barragan E, Bolufer P, Moreno I, Martin G, Nomdedeu J, Brunet S et al. Quantitative detection of AML1 \u2013 ETO rearrangement by real-time RT-PCR using fluorescently labeled probes. Leukemia Lymphoma 2001; 42: 747\u2013756.", "journal-title": "Leukemia Lymphoma"}, {"key": "BF2402959_CR38", "doi-asserted-by": "publisher", "first-page": "369", "DOI": "10.1080/10245332.2000.11746532", "volume": "5", "author": "J Krauter", "year": "2001", "unstructured": "Krauter J, Heil G, Ganser A . The AML1/MTG8 fusion transcript in t(8;21) positive AML and its implication for the detection of minimal residual disease. Hematol 2001; 5: 369\u2013381.", "journal-title": "Hematol"}, {"key": "BF2402959_CR39", "doi-asserted-by": "publisher", "first-page": "342", "DOI": "10.1002/gcc.1100", "volume": "30", "author": "J Krauter", "year": "2001", "unstructured": "Krauter J, Hoellge W, Wattjes MP, Nagel S, Heidenreich O, Bunjes D et al. Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCR. Genes Chromosomes Cancer 2001; 30: 342\u2013348.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2402959_CR40", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1002/(SICI)1098-2264(199912)26:4<355::AID-GCC10>3.0.CO;2-3", "volume": "26", "author": "N Pallisgaard", "year": "1999", "unstructured": "Pallisgaard N, Clausen N, Schroder H, Hokland P . Rapid and sensitive minimal residual disease detection in acute leukemia by quantitative real-time RT-PCR exemplified by t(12;21) TEL\u2013AML1 fusion transcript. Genes Chromosomes Cancer 1999; 26: 355\u2013365.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2402959_CR41", "doi-asserted-by": "publisher", "first-page": "1176", "DOI": "10.1038/sj.leu.2402478", "volume": "16", "author": "A Guerrasio", "year": "2002", "unstructured": "Guerrasio A, Pilatrino C, De Micheli D, Cilloni D, Serra A, Gottardi E et al. Assessment of minimal residual disease (MRD) in CBFbeta/MYH 11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. Leukemia 2002; 16: 1176\u20131181.", "journal-title": "Leukemia"}, {"key": "BF2402959_CR42", "doi-asserted-by": "publisher", "first-page": "443", "DOI": "10.1182/blood.V99.2.443", "volume": "99", "author": "S Buonamici", "year": "2002", "unstructured": "Buonamici S, Ottaviani E, Testoni N, Montefusco V, Visani G, Bonifazi F et al. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state. Blood 2002; 99: 443\u2013449.", "journal-title": "Blood"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2402959.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402959", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2402959.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 17]], "date-time": "2019-03-17T05:44:31Z", "timestamp": 1552801471000}, "score": 31.780613, "issued": {"date-parts": [[2003, 5, 23]]}, "references-count": 42, "journal-issue": {"published-print": {"date-parts": [[2003, 6]]}, "issue": "6"}, "alternative-id": ["BF2402959"], "URL": "http://dx.doi.org/10.1038/sj.leu.2402959", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:13:45Z", "timestamp": 1575530025703}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "22", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2016, 12, 2]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>The fusion of the genes for core binding factor beta and smooth muscle myosin heavy chain (CBFB-MYH11) is the recurrent mutation found in inversion 16 (inv(16)) acute myeloid leukemia (AML). The expressed fusion protein, CBF\u03b2-SMMHC, binds to the transcriptional regulator RUNX1, and this interaction is required for leukemogenesis. Recent data shows CBF\u03b2-SMMHC and RUNX1 are associated with promoters of both transcribed and repressed genes, implying that the CBF\u03b2-SMMHC:RUNX1 complex directly regulates target gene expression. However, it is not known whether other transcriptional co-factors are also required for this activity.</jats:p>\n               <jats:p>Histone deacetylase 1 (HDAC1) removes acetyl groups from histone tails to regulate the accessibility of chromatin to transcriptional machinery. It is recruited to chromatin by transcription factors, including RUNX1. HDAC1 also colocalizes with RUNX1 and CBF\u03b2-SMMHC to promoter regions in ME-1 cells, a human inv(16) cell line. Based on this, we hypothesized that HDAC1 could bind to the RUNX1: CBF\u03b2-SMMHC complex and plays a role in transcriptional regulation in inv(16).</jats:p>\n               <jats:p>To test if CBF\u03b2-SMMHC and HDAC1 form a complex, we transfected COS-7 cells with expression plasmids for HDAC1-FLAG and CBF\u03b2-SMMHC and performed immunoprecipitations (IP) with nuclear extracts. IP with anti-MYH11 showed an interaction between HDAC1 and CBF\u03b2-SMMHC, as did IP with anti-FLAG. Importantly, we found that HDAC1 and CBF\u03b2-SMMHC co-immunoprecipitate in mouse leukemia cells from our knockin model which expresses CBF\u03b2-SMMHC from the endogenous CBF\u03b2 promoter (CBF\u03b2-SMMHC+). Confirming the specificity of this interaction, we found that IP with anti-MYH11 in ME-1 cells shows HDAC1 interaction, but the same IP in the t(8;21) AML cell line Kasumi-1 did not show HDAC1 interaction even though similar levels of HDAC1 are expressed.</jats:p>\n               <jats:p>We next tested whether RUNX1 mediates the interaction between CBF\u03b2-SMMHC and HDAC1. We performed IP experiments using a CBF\u03b2-SMMHC mutant lacking RUNX1 binding (CBF\u03b2-SMMHCN63K,N104K,\u0394179-221). This mutant was co-immunoprecipitated with HDAC1, but not RUNX1, indicating that CBF\u03b2-SMMHC's interaction with HDAC1 does not require RUNX1. We tested a construct lacking the c-terminal 95 amino acids, CBF\u03b2-SMMHC\u0394C95, the domain known to interact with the related protein, HDAC8. We found that HDAC1 immunoprecipitated with CBF\u03b2-SMMHC\u0394C95, suggesting that HDAC1 binds to a unique region of CBF\u03b2-SMMHC.</jats:p>\n               <jats:p>To test if HDAC1 plays a role in CBF\u03b2-SMMHC-mediated gene expression, we performed chromatin immunoprecipitations on mouse CBF\u03b2-SMMHC+ primary leukemia cells with antibodies against HDAC1, RUNX1, and MYH11, followed by real-time PCR for the promoter regions of three CBF\u03b2-SMMHC target genes: MPO, CSF1R, and CEBPD. We observed all three proteins enriched on the target gene promoters as compared to immunoglobulin controls. This indicates that HDAC1 localizes with CBF\u03b2-SMMHC and RUNX1 on target gene promoters in mouse primary leukemia cells. To test if HDAC1 is required for expression of these target genes, we used shRNA to knockdown Hdac1 expression. Mouse CBF\u03b2-SMMHC+ leukemia cells were transduced with one of 2 different shRNAs against Hdac1 or with a control construct. We found that expression of all three genes was decreased with Hdac1knockdown, implying that HDAC1 is required for CBF\u03b2-SMMHC induced changes in gene expression. These results also suggest that HDAC1 may have a role in transcriptional activation for certain genes, which is in contrast to its traditional role as a transcriptional repressor.</jats:p>\n               <jats:p>These findings imply that HDAC1 activity is required for the maintenance of CBF\u03b2-SMMHC expressing leukemia cells, and that HDAC1 inhibitors may be effective against inv(16) AML. To test this possibility we performed colony-forming assays using mouse leukemia cells grown in the presence of two different HDAC inhibitors, entinostat which is specific for HDAC1, and vorinostat, a nonspecific HDAC inhibitor. Our preliminary results indicate that both entinostat and vorinostat reduce the ability of primary CBF\u03b2-SMMHC+ mouse leukemia cells to form colonies as compared to the vehicle control, while having minimal effects on growth of normal hematopoietic cells. In summary, we demonstrated that HDAC1 forms a complex with CBF\u03b2-SMMHC and is required for its regulation of target gene expression, and that HDAC inhibitors may be effective for the treatment of inv(16) AML patients.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosures</jats:title>\n                  <jats:p>No relevant conflicts of interest to declare.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v128.22.2690.2690", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T19:24:48Z", "timestamp": 1570908288000}, "page": "2690-2690", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["HDAC1 Cooperates with CBF\u03b2-SMMHC in Regulating Gene Expression in Inversion 16 Acute Myeloid Leukemia"], "prefix": "10.1182", "volume": "128", "author": [{"given": "Lisa", "family": "Richter", "sequence": "first", "affiliation": [{"name": "Department of Biochemistry and Molecular Biology and the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE"}]}, {"given": "Yiqian", "family": "Wang", "sequence": "additional", "affiliation": [{"name": "Department of Biochemistry and Molecular Biology and the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE"}]}, {"given": "Michelle", "family": "Becker", "sequence": "additional", "affiliation": [{"name": "Department of Biochemistry and Molecular Biology and the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE"}]}, {"given": "R. Katherine", "family": "Hyde", "sequence": "additional", "affiliation": [{"name": "Department of Biochemistry and Molecular Biology and the Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/128/22/2690/113586/HDAC1-Cooperates-with-CBF%CE%B2SMMHC-in-Regulating-Gene", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/128/22/2690/113586/HDAC1-Cooperates-with-CBF%CE%B2SMMHC-in-Regulating-Gene", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T19:55:49Z", "timestamp": 1574193349000}, "score": 31.500307, "issued": {"date-parts": [[2016, 12, 2]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2016, 12, 2]]}, "issue": "22"}, "URL": "http://dx.doi.org/10.1182/blood.v128.22.2690.2690", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:27:45Z", "timestamp": 1574317665750}, "reference-count": 25, "publisher": "Springer Science and Business Media LLC", "issue": "9", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2007, 8, 22]], "date-time": "2007-08-22T00:00:00Z", "timestamp": 1187740800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2007, 9]]}, "DOI": "10.1038/sj.leu.2404809", "type": "journal-article", "created": {"date-parts": [[2007, 8, 22]], "date-time": "2007-08-22T11:10:02Z", "timestamp": 1187781002000}, "page": "1849-1850", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Nucleophosmin mutations in acute myeloid leukemia in children"], "prefix": "10.1038", "volume": "21", "author": [{"given": "H J", "family": "Lawrence", "sequence": "first", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2007, 8, 22]]}, "reference": [{"key": "BF2404809_CR1", "unstructured": "Mullighan CG, Kennedy A, Zhou X, Radtke I, Phillips LA, Shurtleff SA et al. Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias. Leukemia 2007 (in press).", "DOI": "10.1038/sj.leu.2404808", "doi-asserted-by": "crossref"}, {"key": "BF2404809_CR2", "doi-asserted-by": "publisher", "first-page": "1419", "DOI": "10.1182/blood-2005-03-0899", "volume": "106", "author": "G Cazzaniga", "year": "2005", "unstructured": "Cazzaniga G, Dell'Oro MG, Mecucci C, Giarin E, Masetti R, Rossi V et al. Nucleophosmin mutations in childhood acute myelogenous leukemia with normal karyotype. Blood 2005; 106: 1419\u20131422.", "journal-title": "Blood"}, {"key": "BF2404809_CR3", "doi-asserted-by": "publisher", "first-page": "366", "DOI": "10.1038/sj.leu.2404519", "volume": "21", "author": "C Thiede", "year": "2007", "unstructured": "Thiede C, Creutzig E, Reinhardt D, Ehninger G, Creutzig U . Different types of NPM1mutations in children and adults: evidence for an effect of patient age of the prevalence of the TCTG-tandem duplication in NPM1-exon 12. Leukemia 2007; 21: 366\u2013367.", "journal-title": "Leukemia"}, {"key": "BF2404809_CR4", "unstructured": "Brown P, McIntyre E, Rau R, Meschinchi S, Lacayo N, Dahl G et al. The incidence and clinical significance of nucleophosmin mutations in childhood AML. Blood 2007 [E-pub ahead of print].", "DOI": "10.1182/blood-2007-02-076604", "doi-asserted-by": "crossref"}, {"key": "BF2404809_CR5", "doi-asserted-by": "publisher", "first-page": "3310", "DOI": "10.1158/0008-5472.CAN-05-4316", "volume": "66", "author": "W-C Chou", "year": "2006", "unstructured": "Chou W-C, Tang J-L, Lin L-I, Yao M, Tsay W, Chen C-Y . Nucleophosmin mutations in de novo acute myeloid leukemia: the age-dependent incidences and the stability during disease evolution. Cancer Res 2006; 66: 3310\u20133316.", "journal-title": "Cancer Res"}, {"key": "BF2404809_CR6", "unstructured": "Shimada A, Taki T, Kubota C, Tawa A, Horibe K, Tsuchida M et al. No nucleophosmin mutations in pediatric acute myeloid leukemia with normal karyotype: a study of the Japanese Childhood AML Cooperative Study Group. Leukemia 2007 [E-pub ahead of print].", "DOI": "10.1038/sj.leu.2404625", "doi-asserted-by": "crossref"}, {"key": "BF2404809_CR7", "doi-asserted-by": "publisher", "first-page": "874", "DOI": "10.1182/blood-2006-07-012252", "volume": "109", "author": "B Falini", "year": "2007", "unstructured": "Falini B, Nicoletti I, Martelli MF, Mecucci C . Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features. Blood 2007; 109: 874\u2013885.", "journal-title": "Blood"}, {"key": "BF2404809_CR8", "doi-asserted-by": "publisher", "first-page": "493", "DOI": "10.1038/nrc1885", "volume": "6", "author": "S Grisendi", "year": "2006", "unstructured": "Grisendi S, Mecucci C, Falini B, Pandolfi PP . Nucleophosmin and cancer. Nat Rev Cancer 2006; 6: 493\u2013505.", "journal-title": "Nat Rev Cancer"}, {"key": "BF2404809_CR9", "doi-asserted-by": "publisher", "first-page": "254", "DOI": "10.1056/NEJMoa041974", "volume": "352", "author": "B Falini", "year": "2005", "unstructured": "Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. New Engl J Med 2005; 352: 254\u2013266.", "journal-title": "New Engl J Med"}, {"key": "BF2404809_CR10", "doi-asserted-by": "publisher", "first-page": "147", "DOI": "10.1038/nature03915", "volume": "437", "author": "S Grisendi", "year": "2005", "unstructured": "Grisendi S, Bernardi R, Rossi M, Cheng K, Khandker L, Manova K et al. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005; 437: 147\u2013153.", "journal-title": "Nature"}, {"key": "BF2404809_CR11", "doi-asserted-by": "publisher", "first-page": "899", "DOI": "10.1182/blood-2005-02-0560", "volume": "106", "author": "M Alcalay", "year": "2005", "unstructured": "Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood 2005; 106: 899\u2013902.", "journal-title": "Blood"}, {"key": "BF2404809_CR12", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1097/01.moh.0000208467.63861.d6", "volume": "13", "author": "EA Eklund", "year": "2006", "unstructured": "Eklund EA . The role of HOX genes in myeloid leukemogenesis. Curr Opin Hematol 2006; 13: 67\u201373.", "journal-title": "Curr Opin Hematol"}, {"key": "BF2404809_CR13", "doi-asserted-by": "publisher", "first-page": "531", "DOI": "10.1126/science.286.5439.531", "volume": "286", "author": "TR Golub", "year": "1999", "unstructured": "Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999; 286: 531\u2013537.", "journal-title": "Science"}, {"key": "BF2404809_CR14", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1038/ng765", "volume": "30", "author": "SA Armstrong", "year": "2002", "unstructured": "Armstrong SA, Staunton JE, Silverman LB, Pieters R, den Boer ML, Minden MD et al. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 2002; 30: 41\u201347.", "journal-title": "Nat Genet"}, {"key": "BF2404809_CR15", "doi-asserted-by": "publisher", "first-page": "1456", "DOI": "10.1182/blood-2004-04-1583", "volume": "105", "author": "NA Fischbach", "year": "2005", "unstructured": "Fischbach NA, Rozenfeld S, Shen W-F, Fong S, Chrobak D, Ginzinger D et al. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo. Blood 2005; 105: 1456\u20131466.", "journal-title": "Blood"}, {"key": "BF2404809_CR16", "doi-asserted-by": "publisher", "first-page": "2298", "DOI": "10.1101/gad.1111603", "volume": "17", "author": "PM Ayton", "year": "2003", "unstructured": "Ayton PM, Cleary ML . Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003; 17: 2298\u20132307.", "journal-title": "Genes Dev"}, {"key": "BF2404809_CR17", "doi-asserted-by": "publisher", "first-page": "1823", "DOI": "10.1182/blood-2003-07-2582", "volume": "103", "author": "AR Kumar", "year": "2004", "unstructured": "Kumar AR, Hudson WA, Chen W, Nishiuchi R, Yao Q, Kersey JH . Hoxa9 influences the phenotype but not the incidence of MII-AF9 fusion gene leukemia. Blood 2004; 103: 1823\u20131828.", "journal-title": "Blood"}, {"key": "BF2404809_CR18", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1016/S0959-437X(99)80053-7", "volume": "9", "author": "M van Lohuizen", "year": "1999", "unstructured": "van Lohuizen M . The trithorax-group and polycomb-group chromatin modifiers: implications for disease. Curr Opin Genet Dev 1999; 9: 355\u2013361.", "journal-title": "Curr Opin Genet Dev"}, {"key": "BF2404809_CR19", "doi-asserted-by": "publisher", "first-page": "1103", "DOI": "10.1038/sj.leu.2404149", "volume": "20", "author": "P Gorello", "year": "2006", "unstructured": "Gorello P, Cazzaniga G, Alberti F, Dell'Oro MG, Gottardi E, Specchia G et al. Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations. Leukemia 2006; 20: 1103\u20131108.", "journal-title": "Leukemia"}, {"key": "BF2404809_CR20", "doi-asserted-by": "publisher", "first-page": "3733", "DOI": "10.1182/blood-2005-06-2248", "volume": "106", "author": "S Schnittger", "year": "2005", "unstructured": "Schnittger S, Schoch C, Kern W, Mecucci C, Tshulik C, Martelli MF et al. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood 2005; 106: 3733\u20133739.", "journal-title": "Blood"}, {"key": "BF2404809_CR21", "doi-asserted-by": "publisher", "first-page": "3740", "DOI": "10.1182/blood-2005-05-2164", "volume": "106", "author": "K Dohner", "year": "2005", "unstructured": "Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 2005; 106: 3740\u20133746.", "journal-title": "Blood"}, {"key": "BF2404809_CR22", "doi-asserted-by": "publisher", "first-page": "3747", "DOI": "10.1182/blood-2005-05-2168", "volume": "106", "author": "RGW Verhaak", "year": "2005", "unstructured": "Verhaak RGW, Goudswaard CS, van Putten W, Bijl MA, Sanders MA, Hugens W et al. Mutation in nucleophsomin (NPM1) in acute myeloid leukemia (AML) association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance. Blood 2005; 106: 3747\u20133754.", "journal-title": "Blood"}, {"key": "BF2404809_CR23", "doi-asserted-by": "publisher", "first-page": "4011", "DOI": "10.1182/blood-2005-08-3167", "volume": "107", "author": "C Thiede", "year": "2006", "unstructured": "Thiede C, Koch S, Creutzig E, Steudel C, Illmer T, Schaich M et al. Prevalence and prognostic impact of NPM1mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 2006; 107: 4011\u20134020.", "journal-title": "Blood"}, {"key": "BF2404809_CR24", "doi-asserted-by": "publisher", "first-page": "6a", "DOI": "10.1182/blood-2006-04-016162", "volume": "108", "author": "RF Schlenk", "year": "2006", "unstructured": "Schlenk RF, Corbacioglu A, Krauter J, Bullinger L, Morgan M, Spath D et al. Gene mutations as predictive markers for postremission therapy in younger adults with normal karyotype AML. Blood 2006; 108: 6a.", "journal-title": "Blood"}, {"key": "BF2404809_CR25", "doi-asserted-by": "publisher", "first-page": "4146", "DOI": "10.1182/blood-2006-06-026716", "volume": "108", "author": "L Pasqualucci", "year": "2006", "unstructured": "Pasqualucci L, Liso A, Martelli PM, Bolli N, Pacini R, Tabarrini A et al. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification. Blood 2006; 108: 4146\u20134155.", "journal-title": "Blood"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2404809.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404809", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404809.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T16:49:30Z", "timestamp": 1555606170000}, "score": 31.126854, "issued": {"date-parts": [[2007, 8, 22]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2007, 9]]}, "issue": "9"}, "alternative-id": ["BF2404809"], "URL": "http://dx.doi.org/10.1038/sj.leu.2404809", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:12:06Z", "timestamp": 1575529926641}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "21", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2013, 11, 15]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>Acute myeloid leukemia (AML) is often accompanied with the aberrant expression of transcription factors. In t(8;21) AML, the AML1-ETO fusion protein executes its critical role in leukemogenesis through the interference with hematopoietic transcription factors (TFs) including AML1, C/EBP\u03b1, PU.1 and c-Myb. These transcription factors cooperate to modulate hematopoiesis by regulating their differentiation-related target genes. In our previous work, we have identified that AML1-ETO suppresses the AML1-dependent transactivation of the gene encoding the neutrophil granule protease, cathepsin G (CTSG). However, the detailed mechanisms of AML1-ETO mediated transrepression, especially coordinated regulation of hematopoietic transcription factors, have not been characterized yet. To investigate the regulatory pattern of CTSG by hematopoietic specific transcription factors, we constructed a luciferase reporter containing the CTSG promoter and co-transfect it with AML1, c-Myb, C/EBP\u03b1 or PU.1 to 293T cells. The results of luciferase assays showed that these TFs individually activated the CTSG promoter, and synergistic transactivation occurred between AML1 and c-Myb, C/EBP\u03b1 and PU.1, and PU.1 and c-Myb on the CTSG promoter. Furthermore, AML1/ETO effectively suppressed the transcription factor-dependent transactivation and synergistic transactivation of the CTSG promoter. Chromatin immunoprecipitation assays further demonstrated that AML1-ETO coexisted with these TFs on the CTSG promoter in AML1/ETO-positive Kasumi-1 cell line, indicating AML1-ETO was tethered to the chromatin bound by these TFs. The data suggested that AML1-ETO might act as a negative regulator by interfering the normal function of hematopoietic TFs instead of competing for their binding. In addition, to reveal the underlying mechanism of AML1/ETO-mediated transcription repression at the epigenetic level, we examined the epigenetic status of the CTSG promoter in AML1-ETO negative and positive cells, and found the level of histone H3 Lys9 acetylation on the CTSG promoter was obviously lower in AML1-ETO positive cells than that in AML1-ETO negative cells. The data suggested that AML1-ETO might repress the gene transcription by changing the H3 acetylation status of its target gene. Collectively, our findings demonstrate that AML1-ETO represses the transactivation of the CTSG promoter mediated by multiple hematopoietic transcription factors through a decrease of H3 acetylation.</jats:p>\n               <jats:sec>\n                  <jats:title>Disclosures:</jats:title>\n                  <jats:p>No relevant conflicts of interest to declare.</jats:p>\n               </jats:sec>", "DOI": "10.1182/blood.v122.21.3750.3750", "type": "journal-article", "created": {"date-parts": [[2019, 10, 12]], "date-time": "2019-10-12T15:40:31Z", "timestamp": 1570894831000}, "page": "3750-3750", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 0, "title": ["AML1-ETO Represses Multiple Transcription Factor Induced CTSG Activation by Reducing H3 Acetylation"], "prefix": "10.1182", "volume": "122", "author": [{"given": "Yun", "family": "Tan", "sequence": "first", "affiliation": [{"name": "State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}]}, {"given": "Wen", "family": "Jin", "sequence": "additional", "affiliation": [{"name": "State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}]}, {"given": "Kang", "family": "Wu", "sequence": "additional", "affiliation": [{"name": "State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}]}, {"given": "Kankan", "family": "Wang", "sequence": "additional", "affiliation": [{"name": "State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/122/21/3750/12716/AML1ETO-Represses-Multiple-Transcription-Factor", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/122/21/3750/12716/AML1ETO-Represses-Multiple-Transcription-Factor", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 16]], "date-time": "2019-11-16T11:17:19Z", "timestamp": 1573903039000}, "score": 31.11587, "issued": {"date-parts": [[2013, 11, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2013, 11, 15]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1182/blood.v122.21.3750.3750", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T15:04:28Z", "timestamp": 1574867068754}, "reference-count": 0, "publisher": "American Association for Cancer Research", "content-domain": {"domain": ["aacrjournals.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2018, 7, 1]]}, "DOI": "10.1158/1538-7445.am2018-5419", "type": "proceedings-article", "created": {"date-parts": [[2018, 8, 17]], "date-time": "2018-08-17T20:39:37Z", "timestamp": 1534538377000}, "update-policy": "http://dx.doi.org/10.1158/aacr-crossmark-policy", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Abstract 5419: HDAC1 regulates RUNX1 activity in inv(16) acute myeloid leukemia"], "prefix": "10.1158", "author": [{"given": "Lisa", "family": "Richter", "sequence": "first", "affiliation": []}, {"given": "Yiqian", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Michelle", "family": "Becker", "sequence": "additional", "affiliation": []}, {"given": "Jake", "family": "Williams", "sequence": "additional", "affiliation": []}, {"given": "R. Katherine", "family": "Hyde", "sequence": "additional", "affiliation": []}], "member": "1086", "event": {"name": "Proceedings: AACR Annual Meeting 2018; April 14-18, 2018; Chicago, IL"}, "container-title": ["Molecular and Cellular Biology / Genetics"], "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1538-7445.AM2018-5419", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 18]], "date-time": "2019-05-18T14:42:09Z", "timestamp": 1558190529000}, "score": 30.812496, "issued": {"date-parts": [[2018, 7, 1]]}, "references-count": 0, "alternative-id": ["10.1158/1538-7445.AM2018-5419"], "URL": "http://dx.doi.org/10.1158/1538-7445.am2018-5419"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T15:22:14Z", "timestamp": 1575472934608}, "reference-count": 0, "publisher": "Galenos Yayinevi", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Tjh"], "DOI": "10.4274/tjh.galenos.2019.2019.0126", "type": "journal-article", "created": {"date-parts": [[2019, 7, 9]], "date-time": "2019-07-09T06:11:05Z", "timestamp": 1562652665000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Successful Outcome of a Case of Acute Myeloid Leukemia With t(8;21)/AML-ETO Following Langerhans Cell Histiocytosis"], "prefix": "10.4274", "author": [{"given": "Guangqiang", "family": "Meng", "sequence": "first", "affiliation": []}, {"given": "Jingshi", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Jiancheng", "family": "Huang", "sequence": "additional", "affiliation": []}, {"given": "Yini", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "Na", "family": "Wei", "sequence": "additional", "affiliation": []}, {"given": "Zhao", "family": "Wang", "sequence": "additional", "affiliation": []}], "member": "2811", "published-online": {"date-parts": [[2019, 7, 9]]}, "container-title": ["Turkish Journal of Hematology"], "deposited": {"date-parts": [[2019, 7, 9]], "date-time": "2019-07-09T06:11:06Z", "timestamp": 1562652666000}, "score": 30.767633, "issued": {"date-parts": [[2019, 7, 9]]}, "references-count": 0, "URL": "http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0126", "ISSN": ["1300-7777"], "issn-type": [{"value": "1300-7777", "type": "print"}], "subject": ["Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T19:51:48Z", "timestamp": 1575489108937}, "reference-count": 26, "publisher": "Wiley", "issue": "10", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2015, 9, 1]], "date-time": "2015-09-01T00:00:00Z", "timestamp": 1441065600000}, "delay-in-days": 447, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Pediatr Blood Cancer"], "published-print": {"date-parts": [[2014, 10]]}, "DOI": "10.1002/pbc.25109", "type": "journal-article", "created": {"date-parts": [[2014, 6, 11]], "date-time": "2014-06-11T18:03:15Z", "timestamp": 1402509795000}, "page": "1761-1766", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia"], "prefix": "10.1002", "volume": "61", "author": [{"given": "Li", "family": "Zhang", "sequence": "first", "affiliation": [{"name": "Department of Pediatrics; State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}, {"given": "Zeng", "family": "Cao", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}, {"given": "Min", "family": "Ruan", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}, {"given": "Qiang", "family": "Zeng", "sequence": "additional", "affiliation": [{"name": "Tianjin Centers for Disease Control and Prevention; Tianjin P.R. China"}]}, {"given": "Liang", "family": "Zhao", "sequence": "additional", "affiliation": [{"name": "Tianjin Centers for Disease Control and Prevention; Tianjin P.R. China"}]}, {"given": "Qinghua", "family": "Li", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}, {"given": "Yao", "family": "Zou", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}, {"given": "Jianxiang", "family": "Wang", "sequence": "additional", "affiliation": [{"name": "State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}, {"given": "Xiaofan", "family": "Zhu", "sequence": "additional", "affiliation": [{"name": "Department of Pediatrics; State Key Laboratory of Experimental Hematology; Institute of Hematology and Blood Diseases Hospital; Chinese Academy of Medical Sciences and Peking Union Medical College; Tianjin P.R. China"}]}], "member": "311", "published-online": {"date-parts": [[2014, 6, 11]]}, "reference": [{"key": "10.1002/pbc.25109-BIB0001|pbc25109-cit-0001", "doi-asserted-by": "crossref", "first-page": "2674", "DOI": "10.1200/JCO.2009.24.8997", "article-title": "Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12", "volume": "28", "author": "Harrison", "year": "2010", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pbc.25109-BIB0002|pbc25109-cit-0002", "doi-asserted-by": "crossref", "first-page": "2682", "DOI": "10.1200/JCO.2009.25.6321", "article-title": "Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98", "volume": "28", "author": "von Neuhoff", "year": "2010", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pbc.25109-BIB0003|pbc25109-cit-0003", "first-page": "3707", "article-title": "Chromosomal abnormalities in 478 children with acute myeloid leukemia: Clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 882", "volume": "94", "author": "Raimondi", "year": "1999", "journal-title": "Blood"}, {"key": "10.1002/pbc.25109-BIB0004|pbc25109-cit-0004", "doi-asserted-by": "crossref", "first-page": "3767", "DOI": "10.1200/JCO.1999.17.12.3767", "article-title": "Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered", "volume": "17", "author": "Byrd", "year": "1999", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pbc.25109-BIB0005|pbc25109-cit-0005", "doi-asserted-by": "crossref", "first-page": "5705", "DOI": "10.1200/JCO.2005.15.610", "article-title": "Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): A Cancer and Leukemia Group B study", "volume": "23", "author": "Marcucci", "year": "2005", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pbc.25109-BIB0006|pbc25109-cit-0006", "doi-asserted-by": "crossref", "first-page": "892", "DOI": "10.1111/j.1365-2141.1995.tb05406.x", "article-title": "Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission", "volume": "91", "author": "Satake", "year": "1995", "journal-title": "Br J Haematol"}, {"key": "10.1002/pbc.25109-BIB0007|pbc25109-cit-0007", "first-page": "2183", "article-title": "Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia", "volume": "88", "author": "Jurlander", "year": "1996", "journal-title": "Blood"}, {"key": "10.1002/pbc.25109-BIB0008|pbc25109-cit-0008", "first-page": "4789", "article-title": "Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia", "volume": "87", "author": "Miyamoto", "year": "1996", "journal-title": "Blood"}, {"key": "10.1002/pbc.25109-BIB0009|pbc25109-cit-0009", "doi-asserted-by": "crossref", "first-page": "2826", "DOI": "10.1182/blood-2012-06-435669", "article-title": "Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: Results of the United Kingdom MRC AML-15 trial", "volume": "120", "author": "Yin", "year": "2012", "journal-title": "Blood"}, {"key": "10.1002/pbc.25109-BIB0010|pbc25109-cit-0010", "doi-asserted-by": "crossref", "first-page": "517", "DOI": "10.1080/10428190701817266", "article-title": "A > or =1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse", "volume": "49", "author": "Lane", "year": "2008", "journal-title": "Leuk Lymphoma"}, {"key": "10.1002/pbc.25109-BIB0011|pbc25109-cit-0011", "doi-asserted-by": "crossref", "first-page": "2213", "DOI": "10.1182/blood-2012-10-462879", "article-title": "Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia", "volume": "121", "author": "Jourdan", "year": "2013", "journal-title": "Blood"}, {"key": "10.1002/pbc.25109-BIB0012|pbc25109-cit-0012", "doi-asserted-by": "crossref", "first-page": "329", "DOI": "10.1038/sj.leu.2401679", "article-title": "Comparison of nested competitive RT-PCR and real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21) positive acute myelogenous leukemia", "volume": "14", "author": "Wattjes", "year": "2000", "journal-title": "Leukemia"}, {"key": "10.1002/pbc.25109-BIB0013|pbc25109-cit-0013", "doi-asserted-by": "crossref", "first-page": "1130", "DOI": "10.1038/sj.leu.2402959", "article-title": "Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement", "volume": "17", "author": "Viehmann", "year": "2003", "journal-title": "Leukemia"}, {"key": "10.1002/pbc.25109-BIB0014|pbc25109-cit-0014", "doi-asserted-by": "crossref", "first-page": "951", "DOI": "10.1016/S0145-2126(00)00071-0", "article-title": "Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia", "volume": "24", "author": "Kondo", "year": "2000", "journal-title": "Leuk Res"}, {"key": "10.1002/pbc.25109-BIB0015|pbc25109-cit-0015", "doi-asserted-by": "crossref", "first-page": "4007", "DOI": "10.1200/JCO.2008.18.7948", "article-title": "Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: The AML99 trial from the Japanese Childhood AML Cooperative Study Group", "volume": "27", "author": "Tsukimoto", "year": "2009", "journal-title": "J Clin Oncol"}, {"key": "10.1002/pbc.25109-BIB0016|pbc25109-cit-0016", "doi-asserted-by": "crossref", "first-page": "156", "DOI": "10.1016/0003-2697(87)90021-2", "article-title": "Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction", "volume": "162", "author": "Chomczynski", "year": "1987", "journal-title": "Anal Biochem"}, {"key": "10.1002/pbc.25109-BIB0017|pbc25109-cit-0017", "doi-asserted-by": "crossref", "first-page": "1901", "DOI": "10.1038/sj.leu.2401592", "article-title": "Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia", "volume": "13", "author": "Van Dongen", "year": "1999", "journal-title": "Leukemia"}, {"key": "10.1002/pbc.25109-BIB0018|pbc25109-cit-0018", "doi-asserted-by": "crossref", "first-page": "2318", "DOI": "10.1038/sj.leu.2403135", "article-title": "Standardization and quality control studies of \u201crealtime\u201d quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: A Europe Against Cancer program", "volume": "17", "author": "Gabert", "year": "2003", "journal-title": "Leukemia"}, {"key": "10.1002/pbc.25109-BIB0019|pbc25109-cit-0019", "doi-asserted-by": "crossref", "first-page": "2474", "DOI": "10.1038/sj.leu.2403136", "article-title": "Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using \u201creal-time\u201d quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR). A Europe Against Cancer Program", "volume": "17", "author": "Beillard", "year": "2003", "journal-title": "Leukemia"}, {"key": "10.1002/pbc.25109-BIB0020|pbc25109-cit-0020", "doi-asserted-by": "crossref", "first-page": "427", "DOI": "10.1016/j.clml.2011.03.035", "article-title": "Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia", "volume": "11", "author": "Arellano", "year": "2011", "journal-title": "Clin Lymphoma Myeloma Leuk"}, {"key": "10.1002/pbc.25109-BIB0021|pbc25109-cit-0021", "doi-asserted-by": "crossref", "first-page": "173", "DOI": "10.1038/sj.bjc.6605462", "article-title": "Reporting of prognostic studies of tumour markers: A review of published articles in relation to REMARK guidelines", "volume": "102", "author": "Mallett", "year": "2010", "journal-title": "Br J Cancer"}, {"key": "10.1002/pbc.25109-BIB0022|pbc25109-cit-0022", "doi-asserted-by": "crossref", "first-page": "367", "DOI": "10.1038/sj.leu.2403627", "article-title": "Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21)", "volume": "19", "author": "Leroy", "year": "2005", "journal-title": "Leukemia"}, {"key": "10.1002/pbc.25109-BIB0023|pbc25109-cit-0023", "doi-asserted-by": "crossref", "first-page": "209", "DOI": "10.1111/ejh.12130", "article-title": "Core binding factor acute myeloid leukemia: The impact of age, leukocyte count, molecular findings, and minimal residual disease", "volume": "91", "author": "Hoyos", "year": "2013", "journal-title": "Eur J Haematol"}, {"key": "10.1002/pbc.25109-BIB0024|pbc25109-cit-0024", "doi-asserted-by": "crossref", "first-page": "2372", "DOI": "10.1182/blood-2009-09-241075", "article-title": "Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML", "volume": "115", "author": "Pollard", "year": "2010", "journal-title": "Blood"}, {"key": "10.1002/pbc.25109-BIB0025|pbc25109-cit-0025", "doi-asserted-by": "crossref", "first-page": "7521", "DOI": "10.1073/pnas.97.13.7521", "article-title": "AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation", "volume": "97", "author": "Miyamoto", "year": "2000", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/pbc.25109-BIB0026|pbc25109-cit-0026", "doi-asserted-by": "crossref", "first-page": "786", "DOI": "10.1007/s12185-013-1344-6", "article-title": "Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22)", "volume": "97", "author": "Zhang", "year": "2013", "journal-title": "Int J Hematol"}], "container-title": ["Pediatric Blood & Cancer"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpbc.25109", "content-type": "unspecified", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 8, 11]], "date-time": "2019-08-11T12:49:03Z", "timestamp": 1565527743000}, "score": 30.76562, "subtitle": ["Monitoring of AML1/ETO Transcript in Children"], "issued": {"date-parts": [[2014, 6, 11]]}, "references-count": 26, "journal-issue": {"published-print": {"date-parts": [[2014, 10]]}, "issue": "10"}, "URL": "http://dx.doi.org/10.1002/pbc.25109", "relation": {"cites": []}, "ISSN": ["1545-5009"], "issn-type": [{"value": "1545-5009", "type": "print"}], "subject": ["Pediatrics, Perinatology, and Child Health", "Oncology", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T07:14:38Z", "timestamp": 1574406878478}, "reference-count": 11, "publisher": "Springer Science and Business Media LLC", "issue": "4", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2010, 1, 21]], "date-time": "2010-01-21T00:00:00Z", "timestamp": 1264032000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2010, 4]]}, "DOI": "10.1038/leu.2009.291", "type": "journal-article", "created": {"date-parts": [[2010, 1, 21]], "date-time": "2010-01-21T10:45:25Z", "timestamp": 1264070725000}, "page": "860-861", "source": "Crossref", "is-referenced-by-count": 1, "title": ["NHR4 domain mutations of ETO are probably very infrequent in AML1\u2013ETO positive myeloid leukemia cells"], "prefix": "10.1038", "volume": "24", "author": [{"given": "B", "family": "Hackanson", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Abdelkarim", "sequence": "additional", "affiliation": []}, {"given": "J H", "family": "Jansen", "sequence": "additional", "affiliation": []}, {"given": "M", "family": "L\u00fcbbert", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2010, 1, 21]]}, "reference": [{"key": "BFleu2009291_CR1", "doi-asserted-by": "publisher", "first-page": "6285", "DOI": "10.1200/JCO.2005.05.010", "volume": "23", "author": "S Fr\u00f6hling", "year": "2005", "unstructured": "Fr\u00f6hling S, Scholl C, Gilliland DG, Levine RL . Genetics of myeloid malignancies: pathogenetic and clinical implications. J Clin Oncol 2005; 23: 6285\u20136295.", "journal-title": "J Clin Oncol"}, {"key": "BFleu2009291_CR2", "doi-asserted-by": "publisher", "first-page": "115", "DOI": "10.1016/S0268-960X(03)00040-7", "volume": "18", "author": "K Mr\u00f3zek", "year": "2004", "unstructured": "Mr\u00f3zek K, Heerema NA, Bloomfield CD . Cytogenetics in acute leukemia. Blood Rev 2004; 18: 115\u2013136.", "journal-title": "Blood Rev"}, {"key": "BFleu2009291_CR3", "doi-asserted-by": "publisher", "first-page": "483", "DOI": "10.1016/j.ccr.2007.04.010", "volume": "11", "author": "Y Liu", "year": "2007", "unstructured": "Liu Y, Chen W, Gaudet J, Cheney MD, Roudaia L, Cierpicki T et al. Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity. Cancer Cell 2007; 11: 483\u2013497.", "journal-title": "Cancer Cell"}, {"key": "BFleu2009291_CR4", "doi-asserted-by": "publisher", "first-page": "17103", "DOI": "10.1073/pnas.0802696105", "volume": "105", "author": "EY Ahn", "year": "2008", "unstructured": "Ahn EY, Yan M, Malakhova OA, Lo MC, Boyapati A, Ommen HB et al. Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis. Proc Natl Acad Sci USA 2008; 105: 17103\u201317108.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BFleu2009291_CR5", "doi-asserted-by": "publisher", "first-page": "63", "DOI": "10.1016/S1535-6108(02)00016-8", "volume": "1", "author": "M Higuchi", "year": "2002", "unstructured": "Higuchi M, O\u2019Brien D, Kumaravelu P, Lenny N, Yeoh EJ, Downing JR . Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. Cancer Cell 2002; 1: 63\u201374.", "journal-title": "Cancer Cell"}, {"key": "BFleu2009291_CR6", "doi-asserted-by": "publisher", "first-page": "1301", "DOI": "10.3324/haematol.2009.005744", "volume": "94", "author": "T Akagi", "year": "2009", "unstructured": "Akagi T, Shih LY, Ogawa S, Gerss J, Moore SR, Schreck R et al. Single nucleotide polymorphism genomic arrays analysis of t(8;21) acute myeloid leukemia cells. Haematologica 2009; 94: 1301\u20131306.", "journal-title": "Haematologica"}, {"key": "BFleu2009291_CR7", "doi-asserted-by": "publisher", "first-page": "2159", "DOI": "10.1172/JCI24225", "volume": "115", "author": "C Schessl", "year": "2005", "unstructured": "Schessl C, Rawat VP, Cusan M, Deshpande A, Kohl TM, Rosten PM et al. The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice. J Clin Invest 2005; 115: 2159\u20132168.", "journal-title": "J Clin Invest"}, {"key": "BFleu2009291_CR8", "doi-asserted-by": "publisher", "first-page": "183", "DOI": "10.1038/sj.leu.2404465", "volume": "21", "author": "S Schnittger", "year": "2007", "unstructured": "Schnittger S, Bacher U, Kern W, Haferlach C, Haferlach T . JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML. Leukemia 2007; 21: 183\u2013184.", "journal-title": "Leukemia"}, {"key": "BFleu2009291_CR9", "first-page": "920", "volume": "89", "author": "A Beghini", "year": "2004", "unstructured": "Beghini A, Ripamonti CB, Cairoli R, Cazzaniga G, Colapietro P, Elice F et al. KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication. Haematologica 2004; 89: 920\u2013925.", "journal-title": "Haematologica"}, {"key": "BFleu2009291_CR10", "doi-asserted-by": "publisher", "first-page": "3904", "DOI": "10.1200/JCO.2006.06.9500", "volume": "24", "author": "P Paschka", "year": "2006", "unstructured": "Paschka P, Marcucci G, Ruppert AS, Mr\u00f3zek K, Chen H, Kittles RA et al. Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study. J Clin Oncol 2006; 24: 3904\u20133911.", "journal-title": "J Clin Oncol"}, {"key": "BFleu2009291_CR11", "doi-asserted-by": "publisher", "first-page": "5759", "DOI": "10.1038/onc.2008.196", "volume": "27", "author": "AM M\u00fcller", "year": "2008", "unstructured": "M\u00fcller AM, Duque J, Shizuru JA, L\u00fcbbert M . Complementing mutations in core binding factor leukemias: from mouse models to clinical applications. Oncogene 2008; 27: 5759\u20135773.", "journal-title": "Oncogene"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/leu2009291.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu2009291", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/leu2009291.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T11:28:27Z", "timestamp": 1555586907000}, "score": 30.693125, "issued": {"date-parts": [[2010, 1, 21]]}, "references-count": 11, "journal-issue": {"published-print": {"date-parts": [[2010, 4]]}, "issue": "4"}, "alternative-id": ["BFleu2009291"], "URL": "http://dx.doi.org/10.1038/leu.2009.291", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T09:18:39Z", "timestamp": 1575191919893}, "reference-count": 52, "publisher": "Springer Science and Business Media LLC", "issue": "2", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2005, 12, 8]], "date-time": "2005-12-08T00:00:00Z", "timestamp": 1134000000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Leukemia"], "published-print": {"date-parts": [[2006, 2]]}, "DOI": "10.1038/sj.leu.2404024", "type": "journal-article", "created": {"date-parts": [[2005, 12, 8]], "date-time": "2005-12-08T08:07:10Z", "timestamp": 1134029230000}, "page": "218-223", "source": "Crossref", "is-referenced-by-count": 79, "title": ["Characterization of fusion partner genes in 114 patients with de novo acute myeloid leukemia and MLL rearrangement"], "prefix": "10.1038", "volume": "20", "author": [{"given": "L-y", "family": "Shih", "sequence": "first", "affiliation": []}, {"given": "D-c", "family": "Liang", "sequence": "additional", "affiliation": []}, {"given": "J-f", "family": "Fu", "sequence": "additional", "affiliation": []}, {"given": "J-h", "family": "Wu", "sequence": "additional", "affiliation": []}, {"given": "P-n", "family": "Wang", "sequence": "additional", "affiliation": []}, {"given": "T-l", "family": "Lin", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Dunn", "sequence": "additional", "affiliation": []}, {"given": "M-c", "family": "Kuo", "sequence": "additional", "affiliation": []}, {"given": "T-c", "family": "Tang", "sequence": "additional", "affiliation": []}, {"given": "T-h", "family": "Lin", "sequence": "additional", "affiliation": []}, {"given": "C-l", "family": "Lai", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2005, 12, 8]]}, "reference": [{"key": "BF2404024_CR1", "doi-asserted-by": "publisher", "first-page": "10735", "DOI": "10.1073/pnas.88.23.10735", "volume": "88", "author": "S Ziemin-van der Poel", "year": "1991", "unstructured": "Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa III R, Patel Y, Harden A et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 1991; 88: 10735\u201310739.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR2", "doi-asserted-by": "publisher", "first-page": "75", "DOI": "10.1002/gcc.2870130202", "volume": "13", "author": "OA Bernard", "year": "1995", "unstructured": "Bernard OA, Berger R . Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosomes Cancer 1995; 13: 75\u201385.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2404024_CR3", "unstructured": "Marschalek R . MLL (myeloid/lymphoid or mixed lineage leukemia). Atlas Genet Cytogenet Oncol Haematol. November 2002. Available at: \n                    http://www.infobiogen.fr/services/chromcancer/Genes/MLL.html\n                    \n                  ."}, {"key": "BF2404024_CR4", "doi-asserted-by": "publisher", "first-page": "449", "DOI": "10.1073/pnas.0406994102", "volume": "102", "author": "C Meyer", "year": "2005", "unstructured": "Meyer C, Schneider B, Reichel M, Angermueller S, Strehl S, Schnittger S et al. Diagnostic tool for the identification of MLL rearrangements including unknown partner genes. Proc Natl Acad Sci USA 2005; 102: 449\u2013454.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR5", "doi-asserted-by": "publisher", "first-page": "909", "DOI": "10.1056/NEJM199309233291302", "volume": "329", "author": "MJ Thirman", "year": "1993", "unstructured": "Thirman MJ, Gill JH, Burnett RC, Mbangkollo D, McCabe NR, Kobayashi H et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N Engl J Med 1993; 329: 909\u2013914.", "journal-title": "N Engl J Med"}, {"key": "BF2404024_CR6", "doi-asserted-by": "publisher", "first-page": "792", "DOI": "10.1038/sj.leu.2401014", "volume": "12", "author": "GJ Swansbury", "year": "1998", "unstructured": "Swansbury GJ, Slater R, Bain BJ, Moorman AV, Secker-Walker LM . Hematological malignancies with t(9;11)(p21\u201322;q23): a laboratory and clinical study of 125 cases. Leukemia 1998; 12: 792\u2013800.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR7", "first-page": "3085", "volume": "8", "author": "S Iida", "year": "1993", "unstructured": "Iida S, Seto M, Yamamoto K, Komatsu H, Tojo A, Asano S et al. MLLT3 gene on 9p22 involved in t(9;11) leukemia encodes a serine/proline rich protein homologous to MLLT1 on 19p13. Oncogene 1993; 8: 3085\u20133092.", "journal-title": "Oncogene"}, {"key": "BF2404024_CR8", "doi-asserted-by": "publisher", "first-page": "788", "DOI": "10.1038/sj.leu.2401013", "volume": "12", "author": "M Martineau", "year": "1998", "unstructured": "Martineau M, Berger R, Lillington DM, Moorman AV, Secker-Walker LM . The t(6;11)(q27;q23) translocation in acute leukemia: a laboratory and clinical study of 30 cases. Leukemia 1998; 12: 788\u2013791.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR9", "doi-asserted-by": "publisher", "first-page": "801", "DOI": "10.1038/sj.leu.2401015", "volume": "12", "author": "DM Lillington", "year": "1998", "unstructured": "Lillington DM, Young BD, Berger R, Martineau M, Moorman AV, Secker-Walker LM . The t(10;11)(p12;q23) translocation in acute leukaemia: a cytogenetic and clinical study of 20 patients. European 11q23 Workshop participants. Leukemia 1998; 12: 801\u2013804.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR10", "doi-asserted-by": "publisher", "first-page": "805", "DOI": "10.1038/sj.leu.2401016", "volume": "12", "author": "AV Moorman", "year": "1998", "unstructured": "Moorman AV, Hagemeijer A, Charrin C, Rieder H, Secker-Walker LM . The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. Leukemia 1998; 12: 805\u2013810.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR11", "first-page": "5624", "volume": "53", "author": "R Prasad", "year": "1993", "unstructured": "Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H et al. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukemias with the t(6;11) chromosome translocation. Cancer Res 1993; 53: 5624\u20135628.", "journal-title": "Cancer Res"}, {"key": "BF2404024_CR12", "first-page": "2073", "volume": "86", "author": "T Chaplin", "year": "1995", "unstructured": "Chaplin T, Bernard O, Beverloo HB, Saha V, Hagemeijer A, Berger R et al. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. Blood 1995; 86: 2073\u20132076.", "journal-title": "Blood"}, {"key": "BF2404024_CR13", "doi-asserted-by": "publisher", "first-page": "12110", "DOI": "10.1073/pnas.91.25.12110", "volume": "91", "author": "MJ Thirman", "year": "1994", "unstructured": "Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD . Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia. Proc Natl Acad Sci USA 1994; 91: 12110\u201312114.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR14", "first-page": "1747", "volume": "84", "author": "JE Rubnitz", "year": "1994", "unstructured": "Rubnitz JE, Morrissey J, Savage PA, Cleary M . ENL, the gene fused with HRX in t(11;19) leukemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994; 84: 1747\u20131752.", "journal-title": "Blood"}, {"key": "BF2404024_CR15", "doi-asserted-by": "publisher", "first-page": "6236", "DOI": "10.1073/pnas.91.13.6236", "volume": "91", "author": "SA Schichman", "year": "1994", "unstructured": "Schichman SA, Caligiuri MA, Gu Y, Strout MP, Canaani E, Bloomfield CD et al. ALL-1 partial duplication in acute leukemia. Proc Natl Acad Sci USA 1994; 91: 6236\u20136239.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR16", "first-page": "55", "volume": "58", "author": "MA Caligiuri", "year": "1998", "unstructured": "Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res 1998; 58: 55\u201359.", "journal-title": "Cancer Res"}, {"key": "BF2404024_CR17", "doi-asserted-by": "publisher", "first-page": "25", "DOI": "10.1038/sj.leu.2400853", "volume": "12", "author": "E Archimbaud", "year": "1998", "unstructured": "Archimbaud E, Charrin C, Magaud JP, Campos L, Thomas X, Fiere D et al. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint. Leukemia 1998; 12: 25\u201333.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR18", "doi-asserted-by": "publisher", "first-page": "1713", "DOI": "10.1038/sj.leu.2401512", "volume": "13", "author": "S Mathew", "year": "1999", "unstructured": "Mathew S, Behm F, Dalton J, Raimondi S . Comparison of cytogenetics, Southern blotting, and fluorescence in situ hybridization as methods for detecting MLL gene rearrangements in children with acute leukemia and with 11q23 abnormalities. Leukemia 1999; 13: 1713\u20131720.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR19", "first-page": "2912", "volume": "83", "author": "K Yamamoto", "year": "1994", "unstructured": "Yamamoto K, Seto M, Lida S, Komatsu H, Kamada N, Kojima S et al. A reverse transcriptase-polymerase chain reaction detects heterogeneous chimeric mRNAs in leukemias with 11q23 abnormalities. Blood 1994; 83: 2912\u20132921.", "journal-title": "Blood"}, {"key": "BF2404024_CR20", "doi-asserted-by": "publisher", "first-page": "2395", "DOI": "10.1182/blood-2003-02-0434", "volume": "102", "author": "C Schoch", "year": "2003", "unstructured": "Schoch C, Schnittger S, Klaus M, Kern W, Hiddemann W, Haferlach T . AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML cases. Blood 2003; 102: 2395\u20132402.", "journal-title": "Blood"}, {"key": "BF2404024_CR21", "first-page": "3776", "volume": "84", "author": "M Bower", "year": "1994", "unstructured": "Bower M, Parry P, Carter M, Lillington DM, Amess J, Lister TA et al. Prevalence and clinical correlations of MLL gene rearrangements in AML-M4/5. Blood 1994; 84: 3776\u20133780.", "journal-title": "Blood"}, {"key": "BF2404024_CR22", "first-page": "2496", "volume": "87", "author": "H Poirel", "year": "1996", "unstructured": "Poirel H, Rack K, Delabesse E, Radford-Weiss I, Troussard X, Debert C et al. Incidence and characterization of MLL gene (11q23) rearrangements in acute myeloid leukemia M1 and M5. Blood 1996; 87: 2496\u20132505.", "journal-title": "Blood"}, {"key": "BF2404024_CR23", "first-page": "117", "volume": "57", "author": "CW So", "year": "1997", "unstructured": "So CW, Ma ZG, Price CM, Dong S, Chen SJ, Gu LJ et al. Wiedemann LM. Chan LC. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res 1997; 57: 117\u2013122.", "journal-title": "Cancer Res"}, {"key": "BF2404024_CR24", "doi-asserted-by": "publisher", "first-page": "876", "DOI": "10.1038/sj.leu.2402900", "volume": "17", "author": "N Watanabe", "year": "2003", "unstructured": "Watanabe N, Kobayashi H, Ichiji O, Yoshida MA, Kikuta A, Komada Y et al. Cryptic insertion and translocation or nondividing leukemic cells disclosed by FISH analysis in infant acute leukemia with discrepant molecular and cytogenetic findings. Leukemia 2003; 17: 876\u2013882.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR25", "doi-asserted-by": "publisher", "first-page": "27", "DOI": "10.1016/S0165-4608(00)00316-2", "volume": "124", "author": "K Tanaka", "year": "2001", "unstructured": "Tanaka K, Eguchi M, Eguchi-Ishimae M, Hasegawa A, Ohgami A, Kikuchi M et al. Restricted chromosome breakpoint sites on 11q22\u2013q23.1 and 11q25 in various hematological malignancies without MLL/ALL-1 gene rearrangement. Cancer Genet Cytogenet 2001; 124: 27\u201335.", "journal-title": "Cancer Genet Cytogenet"}, {"key": "BF2404024_CR26", "first-page": "1014", "volume": "87", "author": "E Giugliano", "year": "2002", "unstructured": "Giugliano E, Rege-Cambrin G, Scaravaglio P, Wlodarska I, Emanuel B, Stul M et al. Two new translocations involving the 11q23 region map outside the MLL locus in myeloid leukemias. Haematologica 2002; 87: 1014\u20131020.", "journal-title": "Haematologica"}, {"key": "BF2404024_CR27", "doi-asserted-by": "publisher", "first-page": "298", "DOI": "10.1309/RX27R8GJQM330C22", "volume": "122", "author": "MC Cox", "year": "2004", "unstructured": "Cox MC, Panetta P, Lo-Coco F, Del Poeta G, Venditti A, Maurillo L et al. Chromosomal aberration of the 11q23 locus in acute leukemia and frequency of MLL gene translocation: results in 378 adult patients. Am J Clin Pathol 2004; 122: 298\u2013306.", "journal-title": "Am J Clin Pathol"}, {"key": "BF2404024_CR28", "doi-asserted-by": "publisher", "first-page": "2387", "DOI": "10.1182/blood-2002-01-0195", "volume": "100", "author": "LY Shih", "year": "2002", "unstructured": "Shih LY, Huang CF, Wu JH, Lin TL, Dunn P, Wang PN et al. Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse. Blood 2002; 100: 2387\u20132392.", "journal-title": "Blood"}, {"key": "BF2404024_CR29", "doi-asserted-by": "publisher", "first-page": "555", "DOI": "10.1002/mpo.1254", "volume": "37", "author": "DC Liang", "year": "2001", "unstructured": "Liang DC, Shih LY, Yang CP, Hung IJ, Chen SH, Liu HC . Molecular analysis of fusion transcripts in childhood acute myeloid leukemia in Taiwan. Med Pediatr Oncol 2001; 37: 555\u2013556.", "journal-title": "Med Pediatr Oncol"}, {"key": "BF2404024_CR30", "doi-asserted-by": "publisher", "first-page": "3292", "DOI": "10.1002/cncr.10598", "volume": "94", "author": "DC Liang", "year": "2002", "unstructured": "Liang DC, Shih LY, Hung IJ, Yang CP, Chen SH, Jaing TH et al. Clinical relevance of internal tandem duplication of the FLT3 gene in childhood acute myeloid leukemia. Cancer 2002; 94: 3292\u20133298.", "journal-title": "Cancer"}, {"key": "BF2404024_CR31", "first-page": "4804", "volume": "87", "author": "JE Rubnitz", "year": "1996", "unstructured": "Rubnitz JE, Behm FG, Curcio-Brint AM, Pinheiro RP, Carroll AJ, Raimondi SC et al. Molecular analysis of t(11;19) breakpoints in childhood acute leukemias. Blood 1996; 87: 4804\u20134808.", "journal-title": "Blood"}, {"key": "BF2404024_CR32", "first-page": "210", "volume": "9", "author": "R Repp", "year": "1995", "unstructured": "Repp R, Borkhardt A, Haupt E, Kreuder J, Brettreich S, Hammermann J et al. Detection of four different 11q23 chromosomal abnormalities by multiplex-PCR and fluorescence-based automatic DNA-fragment analysis. Leukemia 1995; 9: 210\u2013215.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR33", "first-page": "650", "volume": "85", "author": "W Tse", "year": "1995", "unstructured": "Tse W, Zhu W, Chen HS, Cohen A . A novel gene, AF1q, fused to MLL in t(1;11) (q21;q23), is specifically expressed in leukemic and immature hematopoietic cells. Blood 1995; 85: 650\u2013656.", "journal-title": "Blood"}, {"key": "BF2404024_CR34", "doi-asserted-by": "publisher", "first-page": "2814", "DOI": "10.1073/pnas.050397097", "volume": "97", "author": "MD Megonigal", "year": "2000", "unstructured": "Megonigal MD, Cheung NK, Rappaport EF, Nowell PC, Wilson RB, Jones DH et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc Natl Acad Sci USA 2000; 97: 2814\u20132819.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR35", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1002/gcc.10204", "volume": "37", "author": "JF Fu", "year": "2003", "unstructured": "Fu JF, Hsu JJ, Tang TC, Shih LY . Identification of CBL, a proto-oncogene at 11q23.3, as a novel MLL fusion partner in a patient with de novo acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37: 214\u2013219.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2404024_CR36", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1002/gcc.10272", "volume": "38", "author": "JF Fu", "year": "2003", "unstructured": "Fu JF, Liang DC, Yang CP, Hsu JJ, Shih LY . Molecular analysis of t(X;11)(q24;q23) in an infant with AML-M4. Genes Chromosomes Cancer 2003; 38: 253\u2013259.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2404024_CR37", "doi-asserted-by": "publisher", "first-page": "2292", "DOI": "10.1182/blood-2002-04-1199", "volume": "100", "author": "JW Vardiman", "year": "2002", "unstructured": "Vardiman JW, Harris NL, Brunning RD . The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002; 100: 2292\u20132302.", "journal-title": "Blood"}, {"key": "BF2404024_CR38", "doi-asserted-by": "publisher", "first-page": "4325", "DOI": "10.1182/blood-2002-03-0772", "volume": "100", "author": "JC Byrd", "year": "2002", "unstructured": "Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Cancer and Leukemia Group B (CALGB 8461). Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325\u20134336.", "journal-title": "Blood"}, {"key": "BF2404024_CR39", "first-page": "2322", "volume": "92", "author": "D Grimwade", "year": "1998", "unstructured": "Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322\u20132333.", "journal-title": "Blood"}, {"key": "BF2404024_CR40", "doi-asserted-by": "publisher", "first-page": "1312", "DOI": "10.1182/blood.V98.5.1312", "volume": "98", "author": "D Grimwade", "year": "2001", "unstructured": "Grimwade D, Walker H, Harrison G, Oliver F, Chatters S, Harrison CJ et al. Medical Research Council Adult Leukemia Working Party. The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood 2001; 98: 1312\u20131320.", "journal-title": "Blood"}, {"key": "BF2404024_CR41", "first-page": "4075", "volume": "96", "author": "ML Slovak", "year": "2000", "unstructured": "Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075\u20134083.", "journal-title": "Blood"}, {"key": "BF2404024_CR42", "first-page": "4532", "volume": "90", "author": "K Mrozek", "year": "1997", "unstructured": "Mrozek K, Heinonen K, Lawrence D, Carroll AJ, Koduru RPK, Rao KW et al. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 1997; 90: 4532\u20134538.", "journal-title": "Blood"}, {"key": "BF2404024_CR43", "first-page": "95", "volume": "9", "author": "JA Martinez-Climent", "year": "1995", "unstructured": "Martinez-Climent JA, Lane NJ, Rubin CM, Morgan E, Johnstone HS, Mick R et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995; 9: 95\u2013101.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR44", "first-page": "3707", "volume": "94", "author": "SC Raimondi", "year": "1999", "unstructured": "Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP et al. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a cooperative pediatric oncology group study-POG 8821. Blood 1999; 94: 3707\u20133716.", "journal-title": "Blood"}, {"key": "BF2404024_CR45", "doi-asserted-by": "publisher", "first-page": "2302", "DOI": "10.1200/JCO.2002.08.023", "volume": "20", "author": "JE Rubnitz", "year": "2002", "unstructured": "Rubnitz JE, Raimondi SC, Tong X, Srivastava DK, Razzouk BI, Shurtleff SA et al. Favorable impact of the t(9;11) in childhood acute myeloid leukemia. J Clin Oncol 2002; 20: 2302\u20132309.", "journal-title": "J Clin Oncol"}, {"key": "BF2404024_CR46", "doi-asserted-by": "publisher", "first-page": "6428", "DOI": "10.1073/pnas.96.11.6428", "volume": "96", "author": "M Osaka", "year": "1999", "unstructured": "Osaka M, Rowley JD, Zeleznik-Le NJ . MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc Natl Acad Sci USA 1999; 96: 6428\u20136433.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR47", "first-page": "4075", "volume": "62", "author": "R Ono", "year": "2002", "unstructured": "Ono R, Taki T, Taketani T, Taniwaki M, Kobayashi H, Hayashi Y . LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res 2002; 62: 4075\u20134080.", "journal-title": "Cancer Res"}, {"key": "BF2404024_CR48", "doi-asserted-by": "publisher", "first-page": "2145", "DOI": "10.1073/pnas.040569197", "volume": "97", "author": "PJ Kourlas", "year": "2000", "unstructured": "Kourlas PJ, Strout MP, Becknell B, Veronese ML, Croce CM, Theil KS et al. Identification of a gene at 11q23 encoding a guanine nucleotide exchange factor: evidence for its fusion with MLL in acute myeloid leukemia. Proc Natl Acad Sci USA 2000; 97: 2145\u20132150.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "BF2404024_CR49", "doi-asserted-by": "publisher", "first-page": "796", "DOI": "10.1038/sj.leu.2401773", "volume": "14", "author": "S Schnittger", "year": "2000", "unstructured": "Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia 2000; 14: 796\u2013804.", "journal-title": "Leukemia"}, {"key": "BF2404024_CR50", "doi-asserted-by": "publisher", "first-page": "237", "DOI": "10.1002/gcc.10219", "volume": "37", "author": "C Steudel", "year": "2003", "unstructured": "Steudel C, Wermke M, Schaich M, Schakel U, Illmer T, Ehninger G et al. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer 2003; 37: 237\u2013251.", "journal-title": "Genes Chromosomes Cancer"}, {"key": "BF2404024_CR51", "doi-asserted-by": "publisher", "first-page": "3254", "DOI": "10.1200/JCO.2002.09.088", "volume": "20", "author": "K D\u00f6hner", "year": "2002", "unstructured": "D\u00f6hner K, Tobis K, Ulrich R, Frohling S, Benner A, Schlenk RF et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16\u201360 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol 2002; 20: 3254\u20133261.", "journal-title": "J Clin Oncol"}, {"key": "BF2404024_CR52", "first-page": "774", "volume": "10", "author": "M Yu", "year": "1996", "unstructured": "Yu M, Honoki K, Andersen J, Paietta E, Nam DK, Yunis JJ . MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia 1996; 10: 774\u2013780.", "journal-title": "Leukemia"}], "container-title": ["Leukemia"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/2404024.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404024", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/2404024.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 18]], "date-time": "2019-03-18T04:09:41Z", "timestamp": 1552882181000}, "score": 30.628609, "issued": {"date-parts": [[2005, 12, 8]]}, "references-count": 52, "journal-issue": {"published-print": {"date-parts": [[2006, 2]]}, "issue": "2"}, "alternative-id": ["BF2404024"], "URL": "http://dx.doi.org/10.1038/sj.leu.2404024", "relation": {"cites": []}, "ISSN": ["0887-6924", "1476-5551"], "issn-type": [{"value": "0887-6924", "type": "print"}, {"value": "1476-5551", "type": "electronic"}], "subject": ["Anesthesiology and Pain Medicine", "Cancer Research", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:25:00Z", "timestamp": 1575530700558}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "4", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1993, 2, 15]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>The (8;21)(q22;q22) translocation is a frequent karyotypic abnormality seen in approximately 40% of patients with acute myeloid leukemia subtype M2 (AML-M2) and an abnormal karyotype. The translocation interrupts two genes, AML1 on chromosome 21 and ETO on chromosome 8, that are consequently fused in the der(8) chromosome to produce a novel chimeric gene and message. Selected genomic DNA probes from chromosome 21 and from chromosome 8 near the breakpoint junction detect rearrangements in the DNA of about 80% of the patients with the rearrangement at diagnosis and in relapse. We analyzed the DNA of 20 patients with t(8;21) AML by standard Southern blot with probes originating from chromosomes 21 and 8 near the breakpoint junction, and we identified rearranged bands in 17 of the 20 patients at diagnosis and in relapse. We also used the polymerase chain reaction (PCR) with appropriate primers from the AML1 and ETO genes to amplify the cDNAs from a cell line with the t(8;21) and from seven AML patients with the t(8;21). We detected a fused transcript in the cell line and in all of the patients analyzed, including three patients who did not show any rearrangement by Southern blot analysis and one patient in hematologic remission, who later relapsed. Combining the results from Southern blot and PCR analysis, we could detect the t(8;21) in all of the patients tested. These results indicate that, whereas several DNA probes used as genetic markers do detect the t(8;21) in most, but not all Southern blots of patients with AML, PCR amplification with primers from AML1 and ETO can be used as a more sensitive and accurate means for detecting this chromosomal abnormality, and for observing the patients' response to therapy.</jats:p>", "DOI": "10.1182/blood.v81.4.883.883", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T19:58:21Z", "timestamp": 1570996701000}, "page": "883-888", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 10, "title": ["Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia"], "prefix": "10.1182", "volume": "81", "author": [{"given": "G", "family": "Nucifora", "sequence": "first", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "DJ", "family": "Birn", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "P", "family": "Erickson", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "J", "family": "Gao", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "MM", "family": "LeBeau", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "HA", "family": "Drabkin", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "JD", "family": "Rowley", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/81/4/883/609278/883.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/81/4/883/609278/883.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T06:45:52Z", "timestamp": 1574232352000}, "score": 30.137566, "issued": {"date-parts": [[1993, 2, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 2, 15]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1182/blood.v81.4.883.883", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T07:18:40Z", "timestamp": 1575530320550}, "reference-count": 0, "publisher": "American Society of Hematology", "issue": "4", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[1993, 2, 15]]}, "abstract": "<jats:p>The (8;21)(q22;q22) translocation is a frequent karyotypic abnormality seen in approximately 40% of patients with acute myeloid leukemia subtype M2 (AML-M2) and an abnormal karyotype. The translocation interrupts two genes, AML1 on chromosome 21 and ETO on chromosome 8, that are consequently fused in the der(8) chromosome to produce a novel chimeric gene and message. Selected genomic DNA probes from chromosome 21 and from chromosome 8 near the breakpoint junction detect rearrangements in the DNA of about 80% of the patients with the rearrangement at diagnosis and in relapse. We analyzed the DNA of 20 patients with t(8;21) AML by standard Southern blot with probes originating from chromosomes 21 and 8 near the breakpoint junction, and we identified rearranged bands in 17 of the 20 patients at diagnosis and in relapse. We also used the polymerase chain reaction (PCR) with appropriate primers from the AML1 and ETO genes to amplify the cDNAs from a cell line with the t(8;21) and from seven AML patients with the t(8;21). We detected a fused transcript in the cell line and in all of the patients analyzed, including three patients who did not show any rearrangement by Southern blot analysis and one patient in hematologic remission, who later relapsed. Combining the results from Southern blot and PCR analysis, we could detect the t(8;21) in all of the patients tested. These results indicate that, whereas several DNA probes used as genetic markers do detect the t(8;21) in most, but not all Southern blots of patients with AML, PCR amplification with primers from AML1 and ETO can be used as a more sensitive and accurate means for detecting this chromosomal abnormality, and for observing the patients' response to therapy.</jats:p>", "DOI": "10.1182/blood.v81.4.883.bloodjournal814883", "type": "journal-article", "created": {"date-parts": [[2019, 10, 13]], "date-time": "2019-10-13T06:28:49Z", "timestamp": 1570948129000}, "page": "883-888", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia"], "prefix": "10.1182", "volume": "81", "author": [{"given": "G", "family": "Nucifora", "sequence": "first", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "DJ", "family": "Birn", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "P", "family": "Erickson", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "J", "family": "Gao", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "MM", "family": "LeBeau", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "HA", "family": "Drabkin", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}, {"given": "JD", "family": "Rowley", "sequence": "additional", "affiliation": [{"name": "Department of Medicine, University of Chicago, IL."}]}], "member": "234", "container-title": ["Blood"], "language": "en", "link": [{"URL": "http://ashpublications.org/blood/article-pdf/81/4/883/226272/883.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "http://ashpublications.org/blood/article-pdf/81/4/883/226272/883.pdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T03:54:57Z", "timestamp": 1574222097000}, "score": 30.137566, "issued": {"date-parts": [[1993, 2, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1993, 2, 15]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1182/blood.v81.4.883.bloodjournal814883", "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}], "subject": ["Immunology", "Cell Biology", "Biochemistry", "Hematology"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T21:13:55Z", "timestamp": 1574889235679}, "reference-count": 13, "publisher": "Informa UK Limited", "issue": "5", "content-domain": {"domain": ["www.tandfonline.com"], "crossmark-restriction": true}, "short-container-title": ["Leukemia & Lymphoma"], "published-print": {"date-parts": [[2019, 4, 16]]}, "DOI": "10.1080/10428194.2018.1520991", "type": "journal-article", "created": {"date-parts": [[2018, 10, 17]], "date-time": "2018-10-17T16:15:44Z", "timestamp": 1539792944000}, "page": "1316-1319", "update-policy": "http://dx.doi.org/10.1080/tandf_crossmark_01", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Co-expression of AML1-ETO and PML-RARa following treatment of de novo acute myeloid leukemia with AML1-ETO"], "prefix": "10.1080", "volume": "60", "author": [{"given": "Shuling", "family": "Zhang", "sequence": "first", "affiliation": [{"name": "The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;"}]}, {"given": "Wei", "family": "Zhou", "sequence": "additional", "affiliation": [{"name": "Respiratory medicine department, Beijing Geriatric Hospital, Beijing, China;"}]}, {"given": "Yanchun", "family": "Li", "sequence": "additional", "affiliation": [{"name": "Department of Hematology, Shanxi Provincial People\u2019s Hospital, Xian, Shanxi, China;"}]}, {"given": "Shuili", "family": "Yu", "sequence": "additional", "affiliation": [{"name": "People\u2019s Hospital of Jingyuan County, Jingyuan, Baiyin, Gansu, China;"}]}, {"given": "Mingming", "family": "Xue", "sequence": "additional", "affiliation": [{"name": "The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;"}]}, {"given": "Yanhong", "family": "Qiao", "sequence": "additional", "affiliation": [{"name": "The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;"}]}, {"given": "Jinli", "family": "Jian", "sequence": "additional", "affiliation": [{"name": "The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;"}]}, {"given": "Bei", "family": "Liu", "sequence": "additional", "affiliation": [{"name": "The First Clinical Medical College, Lanzhou University, Lanzhou, Gansu, China;"}, {"name": "Department of Hematology, The First Affiliated Hospital, Lanzhou University, Lanzhou, Gansu, China;"}]}, {"given": "Degui", "family": "Wang", "sequence": "additional", "affiliation": [{"name": "Department of Anatomy and Histology, Lanzhou University, School of Basic Medical Sciences, Lanzhou, China"}]}], "member": "301", "published-online": {"date-parts": [[2018, 10, 17]]}, "reference": [{"key": "CIT0001", "DOI": "10.1016/0165-4608(92)90108-K", "doi-asserted-by": "publisher"}, {"key": "CIT0002", "DOI": "10.1111/j.1365-2141.2004.05343.x", "doi-asserted-by": "publisher"}, {"key": "CIT0003", "DOI": "10.4274/Tjh.2012.0180", "doi-asserted-by": "publisher"}, {"key": "CIT0004", "DOI": "10.1186/s12935-014-0111-y", "doi-asserted-by": "publisher"}, {"key": "CIT0005", "DOI": "10.1038/sj.leu.2401455", "doi-asserted-by": "publisher"}, {"key": "CIT0006", "DOI": "10.1182/blood-2009-11-254441", "doi-asserted-by": "publisher"}, {"key": "CIT0007", "DOI": "10.1182/blood-2012-05-429050", "doi-asserted-by": "publisher"}, {"key": "CIT0008", "DOI": "10.1182/blood-2011-10-386086", "doi-asserted-by": "publisher"}, {"key": "CIT0009", "DOI": "10.18632/oncotarget.14150", "doi-asserted-by": "publisher"}, {"key": "CIT0010", "DOI": "10.1007/s12032-013-0625-5", "doi-asserted-by": "publisher"}, {"key": "CIT0011", "DOI": "10.1056/NEJMoa042715", "doi-asserted-by": "publisher"}, {"key": "CIT0012", "DOI": "10.3324/haematol.2011.041970", "doi-asserted-by": "publisher"}, {"key": "CIT0013", "DOI": "10.1093/ije/30.2.350", "doi-asserted-by": "publisher"}], "container-title": ["Leukemia & Lymphoma"], "language": "en", "link": [{"URL": "https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1520991", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 18]], "date-time": "2019-04-18T12:18:36Z", "timestamp": 1555589916000}, "score": 30.085516, "issued": {"date-parts": [[2018, 10, 17]]}, "references-count": 13, "journal-issue": {"published-online": {"date-parts": [[2018, 10, 15]]}, "published-print": {"date-parts": [[2019, 4, 16]]}, "issue": "5"}, "alternative-id": ["10.1080/10428194.2018.1520991"], "URL": "http://dx.doi.org/10.1080/10428194.2018.1520991", "relation": {"cites": []}, "ISSN": ["1042-8194", "1029-2403"], "issn-type": [{"value": "1042-8194", "type": "print"}, {"value": "1029-2403", "type": "electronic"}], "assertion": [{"value": "The publishing and review policy for this title is described in its Aims & Scope.", "order": 1, "name": "peerreview_statement", "label": "Peer Review Statement"}, {"value": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ilal20", "URL": "http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ilal20", "order": 2, "name": "aims_and_scope_url", "label": "Aim & Scope"}, {"value": "2018-06-26", "order": 0, "name": "received", "label": "Received", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-08-22", "order": 1, "name": "revised", "label": "Revised", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-09-01", "order": 2, "name": "accepted", "label": "Accepted", "group": {"name": "publication_history", "label": "Publication History"}}, {"value": "2018-10-17", "order": 3, "name": "published", "label": "Published", "group": {"name": "publication_history", "label": "Publication History"}}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}